US20230031760A1 - Intraocular lens with elastic mask - Google Patents
Intraocular lens with elastic mask Download PDFInfo
- Publication number
- US20230031760A1 US20230031760A1 US17/655,430 US202217655430A US2023031760A1 US 20230031760 A1 US20230031760 A1 US 20230031760A1 US 202217655430 A US202217655430 A US 202217655430A US 2023031760 A1 US2023031760 A1 US 2023031760A1
- Authority
- US
- United States
- Prior art keywords
- mask
- lens
- elastic
- intraocular lens
- holes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 claims abstract description 183
- 238000000034 method Methods 0.000 claims abstract description 51
- 230000003287 optical effect Effects 0.000 claims description 38
- 238000002347 injection Methods 0.000 claims description 24
- 239000007924 injection Substances 0.000 claims description 24
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 229920001296 polysiloxane Polymers 0.000 claims description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- 238000004528 spin coating Methods 0.000 claims description 2
- 230000005670 electromagnetic radiation Effects 0.000 claims 2
- 238000002329 infrared spectrum Methods 0.000 claims 2
- 239000007943 implant Substances 0.000 abstract description 23
- 210000000695 crystalline len Anatomy 0.000 description 173
- 210000001525 retina Anatomy 0.000 description 16
- 230000005540 biological transmission Effects 0.000 description 14
- 238000000605 extraction Methods 0.000 description 12
- 239000000126 substance Substances 0.000 description 10
- 230000008901 benefit Effects 0.000 description 9
- 230000004438 eyesight Effects 0.000 description 9
- 238000001723 curing Methods 0.000 description 8
- 230000007704 transition Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 7
- 229920006243 acrylic copolymer Polymers 0.000 description 6
- 210000004087 cornea Anatomy 0.000 description 6
- 210000001747 pupil Anatomy 0.000 description 6
- 230000032798 delamination Effects 0.000 description 5
- 201000010041 presbyopia Diseases 0.000 description 5
- 230000036760 body temperature Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 125000001475 halogen functional group Chemical group 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 208000001491 myopia Diseases 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- 210000002159 anterior chamber Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000006229 carbon black Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- 206010027646 Miosis Diseases 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000036040 emmetropia Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 239000006261 foam material Substances 0.000 description 1
- 230000004313 glare Effects 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 230000004297 night vision Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 208000014733 refractive error Diseases 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000001029 thermal curing Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/15—Implant having one or more holes, e.g. for nutrient transport, for facilitating handling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1648—Multipart lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1659—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having variable absorption coefficient for electromagnetic radiation, e.g. photochromic lenses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
- B29C39/02—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor for making articles of definite length, i.e. discrete articles
- B29C39/026—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor for making articles of definite length, i.e. discrete articles characterised by the shape of the surface
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
- B29C39/02—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor for making articles of definite length, i.e. discrete articles
- B29C39/10—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor for making articles of definite length, i.e. discrete articles incorporating preformed parts or layers, e.g. casting around inserts or for coating articles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/00038—Production of contact lenses
- B29D11/00048—Production of contact lenses composed of parts with dissimilar composition
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/00432—Auxiliary operations, e.g. machines for filling the moulds
- B29D11/00442—Curing the lens material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0018—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0053—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in optical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2101/00—Use of unspecified macromolecular compounds as moulding material
- B29K2101/12—Thermoplastic materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2701/00—Use of unspecified macromolecular compounds for preformed parts, e.g. for inserts
- B29K2701/12—Thermoplastic materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2715/00—Condition, form or state of preformed parts, e.g. inserts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
- B29K2995/0012—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds having particular thermal properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
- B29K2995/0037—Other properties
- B29K2995/0046—Elastic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2011/00—Optical elements, e.g. lenses, prisms
- B29L2011/0016—Lenses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
- B29L2031/7532—Artificial members, protheses
Definitions
- This application relates generally to the field of intraocular devices. More particularly, this application is directed to intraocular implants and lenses (IOLs) with an aperture to increase depth of focus (e.g. “masked” intraocular lenses), and methods of making the same.
- IOLs intraocular implants and lenses
- the human eye functions to provide vision by transmitting and focusing light through a clear outer portion called the cornea, and further refining the focus of the image onto a retina by way of a crystalline lens.
- the quality of the focused image depends on many factors including the size and shape of the eye, and the transparency of the cornea and the lens.
- the optical power of the eye is determined by the optical power of the cornea and the crystalline lens.
- sharp images of distant objects are formed on the retina (emmetropia).
- images of distant objects are either formed in front of the retina because the eye is abnormally long or the cornea is abnormally steep (myopia), or formed in back of the retina because the eye is abnormally short or the cornea is abnormally flat (hyperopia).
- the cornea also may be asymmetric or toric, resulting in an uncompensated cylindrical refractive error referred to as corneal astigmatism.
- IOL intraocular lens
- Certain aspects of this disclosure are directed toward an intraocular lens including a mask embedded within, or secured to, a lens body including a lens material.
- the mask can include an aperture for improving depth of focus.
- the mask can include a mask material having a modulus of elasticity that is within about 30 percent of a modulus of elasticity of the lens material.
- Certain aspects of this disclosure are directed toward an intraocular lens including a mask embedded within, or secured to, a lens body including a lens material.
- the mask can include an aperture for improving depth of focus.
- the mask can include a mask material having a coefficient of thermal expansion that is within about 30 percent of the coefficient of thermal expansion of the lens material.
- the mask material has a coefficient of thermal expansion that is within about 20 percent, within about 10 percent, or within about 5 percent of the coefficient of thermal expansion of the lens material.
- the intraocular lens can be configured such that a pre-injection optical power of the intraocular lens can be within about 0.5 diopters, preferably within about 0.3 diopters, or within about 0.2 diopters, or within about 0.1 diopters, of a post-injection optical power of the intraocular lens.
- the modulus of elasticity of the mask material can be within about 20 percent of the modulus of elasticity of the lens material, or within about 10 percent of the modulus of elasticity of the lens material, or within about 5 percent greater than the modulus of elasticity of the lens material. In some embodiments, the modulus of elasticity of the mask material can be greater than or equal to the modulus of elasticity of the lens material. In some embodiments, the modulus of elasticity of the mask material can be less than the modulus of elasticity of the lens material.
- the mask material can include silicone or acrylic.
- the lens material and the mask material can include the same material.
- the mask can include a plurality of holes characterized in that at least one of a hole size, shape, orientation, and spacing of the plurality of holes is varied to reduce the tendency of the holes to produce visible diffraction patterns.
- the mask can include a thickness of less than or equal to about 200 microns, preferably less than or equal to about 100 microns.
- the thickness can be at least about 4 microns and less than or equal to about 20 microns, or less than or equal to about 15 microns, or less than or equal to about 10 microns.
- the lens body can include an outer diameter between about 3 mm and about 6 mm. Further, the lens body can be capable of insertion through an incision having a chord length of less than or equal to about 3.0 mm or less than or equal to about 2.4 mm.
- the intraocular lens can be configured such that a room temperature optical power of the intraocular lens can be within about 0.15 diopters, such as within about 0.03 diopters of 0.1 diopters, for example, about 0.13 diopters, of a body temperature optical power of the intraocular lens.
- the intraocular lens can undergo a temperature differential of about 10° C. without substantially affecting optical power.
- Certain aspects of this disclosure are directed toward a method of implanting an intraocular lens.
- the method can include creating an incision having a chord length of less than or equal to about 2.4 mm, and injecting an intraocular lens through the incision using an injector system.
- the injected intraocular lens can include a mask embedded within, or secured to, a lens body including a lens material.
- the mask can include an aperture for improving depth of focus.
- the modulus of elasticity of the mask material can be within about 30 percent of the modulus of elasticity of the lens material, or within about 20 percent of the modulus of elasticity of the lens material, or within about 10 percent of the modulus of elasticity of the lens material, or within about 5 percent of the modulus of elasticity of the lens material.
- the modulus of elasticity of the mask material can be greater than or equal to the modulus of elasticity of the lens material.
- the modulus of elasticity of the mask material can be less than the modulus of elasticity of the lens material.
- the intraocular lens can further include any of the aspects of the intraocular lenses described above.
- Certain aspects of this disclosure are directed toward a method of implanting an intraocular lens.
- the method can include creating an incision, injecting an intraocular lens through the incision using an injector system, and introducing the intraocular lens to a temperature differential of at least about 10° C. without substantially affecting optical power.
- the injected intraocular lens can include a mask embedded within, or secured to, a lens body including a lens material.
- the mask can include an aperture for improving depth of focus.
- the mask can include a material having a coefficient of thermal expansion that is within about 30 percent of a coefficient of thermal expansion of the lens material, within about 20 percent of a coefficient of thermal expansion of the lens material, within about 10 percent of a coefficient of thermal expansion of the lens material, or within about 5 percent of a coefficient of thermal expansion of the lens material.
- the intraocular lens can further include any of the aspects of the intraocular lenses described above.
- Certain aspects of this disclosure are directed toward a method of manufacturing an intraocular lens.
- the method can include forming a mask with an aperture for improving depth of focus from a mask material, inserting a lens material into a mold, and curing the lens material to form a lens body.
- the lens body can include the mask therein.
- the lens material can include a modulus of elasticity that is within about 30 percent of a modulus of elasticity of the mask material.
- the intraocular lens can further include any of the aspects of the intraocular lenses described above.
- Certain aspects of this disclosure are directed toward a method of manufacturing an intraocular lens.
- the method can include forming a mask with an aperture for improving depth of focus from a mask material, inserting a lens material into a mold, and curing the lens material to form a lens body.
- the lens body can include the mask therein.
- the lens material can include a coefficient of thermal expansion that is within about 30 percent of a coefficient of thermal expansion of the mask material.
- the intraocular lens can further include any of the aspects of the intraocular lenses described above.
- the method can include forming the mask by spin-casting the mask material, stamping the mask material, printing the mask material, or extruding the mask material.
- the method can include, after curing the lens material, chemically extracting residual lens material.
- FIG. 1 A illustrates a top view of an example embodiment of an intraocular lens having an embedded mask for improving depth of focus.
- FIG. 1 B illustrates a cross-sectional view of the intraocular lens of FIG. 1 A taken along line 1 B- 1 B.
- FIG. 2 A is a perspective view of one embodiment of a mask configured to increase depth of focus.
- FIG. 2 B is a perspective view of an embodiment of a substantially flat mask configured to increase depth of focus.
- FIG. 3 A is a top view of another embodiment of a mask configured to increase depth of focus.
- FIG. 3 B is an enlarged view of a portion of the view of FIG. 3 A .
- FIG. 3 C is a cross-sectional view of the mask of FIG. 3 B taken along line 3 C- 3 C.
- FIG. 4 is a graphical representation of one arrangement of holes of a plurality of holes that may be formed in the mask.
- IOL intraocular lens
- One technique for treating such defects is by including a mask within the IOL that increases the patient's depth of focus.
- the intraocular implants of the embodiments described herein include a mask adapted to provide a small aperture for light to pass through to the retina to increase depth of focus. The light rays that pass through the mask within the IOL converge at substantially a single focal point on the retina, while the light rays that would not converge at the single point on the retina are blocked by the mask.
- multifocal IOLs and accommodating IOLs.
- These devices attempt to provide the ability to see clearly at both near and far distances.
- accommodating IOLs can be complex and some multifocal IOLs do not perform well at intermediate distances and cause glare, halos, and night vision difficulties associated with the presence of unfocused light.
- This limitation can force designers of multifocal optics to choose how much of the light is directed to each focal point, and to deal with the effects of the unfocused light that is always present in any image.
- FIGS. 1 A-B illustrate an example embodiment of an intraocular lens having an embedded mask 1008 for increasing depth of focus.
- the intraocular lens 1000 can include haptics 1004 for positioning the lens within the eye.
- the cross-sectional thickness of the lens body 1002 is generally dependent on the optical power of the intraocular lens 1000 and the material of the lens body 1002 .
- the central region of the lens body 1002 is generally the thickest section of the intraocular lens 1000 with a central region cross-sectional thickness 1006 .
- Methods for reducing the thickness of the intraocular lens are described in U.S. Pub. No. 2011/0040376, filed Aug. 13, 2010, which is incorporated herein by reference in its entirety. Any of the teachings of this prior publication can also be applied to the devices and methods in the present disclosure.
- One method of implanting the IOL 1000 can include inserting the IOL through a small incision in the eye.
- the IOL 1000 can be inserted into the eye using an injector system.
- the injector system can include a cartridge tip for housing the IOL 1000 .
- the size of the hole in the cartridge tip through which the IOL 1000 is injected is typically smaller than the size of the IOL.
- the IOL 1000 is deformed (e.g., stretched) when passing through the tip during the injection process.
- the IOL 1000 can be made of a resilient material such that it can revert back to its pre-injection shape after passing through the cartridge tip.
- the size of the incision is generally dependent on the size of the cartridge tip. Typically, smaller surgical incisions are associated with better surgical outcomes.
- the size of the cartridge tip and incision can be limited by the material properties of the lens body.
- This problem can be further complicated by the embedded mask 1008 within the IOL 1000 .
- the extrusion forces can not only stretch or otherwise deform the IOL but also the embedded mask 1008 .
- the location of the embedded mask 1008 within the IOL 1000 can be displaced (e.g., the embedded mask can become transversely de-centered and/or longitudinally biased to either side of the desired longitudinal depth of the embedded mask within the IOL).
- the IOL 1000 and the embedded mask 1008 After releasing the IOL 1000 from the cartridge tip, it is desirable that the IOL 1000 and the embedded mask 1008 achieve a target post-injection optical performance specification (e.g., optical power, presbyopia correction, etc.). For example, it may be desirable for the post-injection optical performance to substantially match the pre-injection optical performance.
- the IOL 1000 and the embedded mask 1008 have material properties (e.g., elasticity) that allow them to revert back to their pre-injection shapes, and, in the case of the embedded mask, its pre-injection location within the IOL.
- IOL manufacturing processes can involve steps where the IOL swells, undergoes temperature differentials, etc.
- the mask can be deformed if it does not have sufficient elasticity or a compatible coefficient of thermal expansion when compared to the IOL material.
- Some methods of manufacturing the IOL 1000 can include chemically extracting impurities from the IOL.
- the chemical extraction process can be used to remove residual lens material monomer.
- the chemical extraction process can include immersing the IOL in a chemical (e.g., hexane, benzene, or alcohol) over a pre-determined period of time and a particular temperature profile.
- the lens body can undergo a volumetric increase of at least about 10%. If the material properties of the mask material differ too much from the material properties of the lens material, then the mask 1008 can undergo deformation and/or displacement, thus degrading the optical performance of the IOL. This can occur if, for example, the modulus of elasticity of the mask material is much different than the modulus of elasticity of the lens material.
- the mask 1008 and the lens body can be particularly difficult to maintain the desired optical performance through deformations and temperature differentials when the mask 1008 and the lens body exhibit incompatible material properties (e.g. modulus of elasticity or coefficient of thermal expansion). If one or both of the mask material and lens body material do not exhibit appropriate material properties, the mask 1008 and/or lens body can be permanently deformed or, in the case of the embedded mask, biased to an undesired location within the IOL, during deformations (such as those that may occur during chemical extractions), and/or temperature shifts. This can affect optical performance (e.g., optical power or presbyopia correction). For example, if the lens body exhibits greater elasticity than the mask material, then, after injection, the mask 1008 can be deformed and degrade the optical performance of the IOL 1000 .
- incompatible material properties e.g. modulus of elasticity or coefficient of thermal expansion.
- the coefficients of expansion of the lens material and the mask material are too different, when the IOL transitions from room temperature (e.g., about 20° C.) to body temperature (e.g., about 35-37° C.), the resulting stress and strain can cause the mask to be deformed and degrade the optical performance of the IOL.
- the IOLs e.g., 1000
- embedded masks e.g., 1008
- the IOLs include substantially the same optical characteristics pre-injection and post-injection.
- FIG. 2 A illustrates one embodiment of a mask 2034 a .
- the mask 2034 a can include an annular region 2036 a surrounding an aperture 2038 a substantially centrally located on the mask 2034 a .
- the aperture 2038 a can be generally located around a central axis 2039 a , referred to herein as the optical axis of the mask 2034 a .
- the aperture 2038 a can be in the shape of a circle.
- FIG. 2 B illustrates another embodiment of a mask 2034 b similar to the mask 2034 a illustrated in FIG. 2 A .
- FIG. 2 A has a curvature from the outer periphery to the inner periphery of the annular region 2036 a , while the annular region 2036 b of the mask 2034 b of FIG. 2 B can be substantially flat (as shown in FIG. 1 B ).
- the examples provided herein are generally discussed in connection with the mask 2034 b , any of the examples can include the mask 2034 a .
- a variety of variations of masks that can be positioned on or within the implant body are discussed herein, and are also described in U.S. Patent Publication No. 2012/0143325, filed Feb. 10, 2012, which is incorporated by reference herein in its entirety. Any of the teachings of this prior publication can also be applied to the devices and methods in the present disclosure.
- the mask 2034 b can have dimensions adapted to function with the implant body to improve a patient's vision.
- the thickness of the mask 2034 b can vary depending on the location of the mask 2034 b relative to the implant body. For example, if the mask 2034 b is embedded within the implant body, the mask 2034 b can have a thickness greater than zero and less than the thickness of the implant body. Alternatively, if the mask is coupled to a surface of the implant body, the mask 2034 b may have a thickness no greater than necessary to have the desired opacity so that the mask does not add additional thickness to the intraocular lens.
- the mask 2034 b can have a substantially constant thickness. However, in other implementations, the thickness of the mask may vary between the inner periphery (near the aperture 2038 b ) and the outer periphery.
- the thickness of the mask 2034 b can be less than or equal to about 200 microns, or less than or equal to about 100 microns, but preferably between about 1 micron and about 20 microns.
- the thickness of the mask 2034 b can be within the range from about 1 micron to about 40 microns, in the range from about 5 microns to about 20 microns, or otherwise.
- the mask 2034 b can include a thickness of at least about 5 microns and/or less than or equal to about 20 microns.
- the mask 2034 b can include a thickness of at least about 5 microns and/or less than or equal to about 15 microns.
- the thickness can be within two microns of about 15 microns, about 10 microns, about 8 microns, about 5 microns, or otherwise.
- the mask may be a bulk mask and its width may extend across much of the thickness of the lens (e.g., the width of the mask may be at least about 80 percent of the thickness of the implant body or at least about 90 percent of the thickness of the implant body).
- the mask 2034 b can be symmetrical, e.g., symmetrical about a mask axis 2039 b .
- the outer periphery of the mask 2034 b can be circular.
- the mask 2034 b in general can have an outer diameter of at least about 3 mm and/or less than about 6 mm.
- the mask 2034 b can be circular and can include a diameter of at least about 3 mm and/or less than or equal to about 4 mm.
- the mask 2034 b can be circular and can include a diameter within a range of 0.2 mm of about 3.2 mm.
- the aperture 2038 b can be substantially circular and can be substantially centered in the mask 2034 b .
- the size of the aperture 2038 b can be any size that is effective to increase the depth of focus of an eye of a patient with presbyopia.
- the size of the aperture 2038 b can be dependent on the location of the mask within the eye (e.g., distance from the retina).
- the aperture 2038 b can have a diameter of at least about 0.85 mm and/or less than or equal to about 2.2 mm. In certain embodiments, the diameter of the aperture 2038 b is less than or equal to about 2 mm.
- the diameter of the aperture 2038 b is at least about 1.1 mm and/or less than or equal to about 1.6 mm. In some embodiments, the diameter of the aperture 2038 b is at least about 1.3 mm and/or less than or equal to about 1.4 mm.
- the aperture 2038 b can transmit substantially all incident light along the mask axis 2039 b .
- the annular region 2036 b can substantially prevent transmission of incident light thereon.
- the aperture 2038 b can be a through-hole in the annular region 2036 b or a substantially light transmissive (e.g., transparent) portion thereof.
- the aperture 2038 b of the mask 2034 b can be generally defined within the outer periphery of the mask 2034 b.
- the annular region 2036 b can at least partially prevent transmission of visible light through the mask 2034 b .
- the annular region 2036 b can prevent transmission of substantially all or at least a portion of the spectrum of the incident visible light.
- the annular region 2036 b can prevent transmission of substantially all visible light, e.g., radiant energy in the electromagnetic spectrum that is visible to the human eye.
- the annular region 2036 b can substantially prevent transmission of radiant energy outside the range visible to humans in some embodiments.
- Preventing transmission of light through the annular region 2036 b can decrease the amount of light that reaches the retina and the fovea that would not converge at the retina and fovea to form a sharp image.
- the size of the aperture 2038 b is such that the light transmitted therethrough generally converges at the retina or fovea. Accordingly, a much sharper image can be presented to the retina than would otherwise be the case without the mask 2034 b.
- the annular region 2036 b can prevent transmission of at least about 90 percent of incident light. In some embodiments, the annular region 2036 b can prevent transmission of at least about 92 percent, at least about 95 percent, or at least about 98 percent of all incident light.
- the annular region 2036 b of the mask 2034 b can be substantially opaque to prevent the transmission of light.
- the annular region 2036 b can transmit no more than about 5% of incident visible light. In some embodiments, the annular region 2036 b can transmit no more than about 3 percent of incident visible light. In some embodiments, the annular region 2036 b can transmit no more than about 2 percent of incident visible light. In some embodiments, at least a portion of the annular region 2036 b can be opaque to more than 99 percent of the light incident thereon.
- the annular region 2036 b can prevent at least partial transmission of light without absorbing the incident light.
- the mask 2034 b can be reflective or can interact with the light in a more complex manner, as discussed in U.S. Pat. No. 6,554,424, issued Apr. 29, 2003, which is hereby incorporated by reference in its entirety.
- the annular region 2036 b can be at least partially opaque or can be completely opaque.
- the degree of opacity of the annular region 2036 b can prevent at least some or substantially all light from being transmitted through the mask 2034 b .
- Opacity of the annular region 2036 b can be achieved in any of several different ways.
- the material used to make mask 2034 b can be naturally opaque.
- the material used to make the mask 2034 b can be substantially clear, but treated with a dye or other pigmentation agent to render region 2036 b substantially or completely opaque.
- the mask can include carbon black.
- the surface of the mask 2034 b can be treated physically or chemically (such as by etching) to alter the refractive and transmissive properties of the mask 2034 b and make it less transmissive to light.
- a photochromic material can be used as the mask or in addition to mask. Under bright light conditions, the photochromic material can darken thereby creating a mask and enhancing near vision. Under dim light conditions, the photochromic material can lighten, which allows more light to pass through to the retina. In certain embodiments, under dim light conditions, the photochromic material lightens to expose an optic of the intraocular implant. Further photochromic material details are disclosed in U.S. Patent Publication No. 2013/0268071, filed Nov. 30, 2012, which is hereby incorporated by reference in its entirety.
- the mask can transition between different degrees of opacity. For example, at least a portion of the mask can transition between at least a first degree of opacity and a second degree of opacity. Further details are disclosed in U.S. application Ser. No. 13/830,889, filed Mar. 14, 2013, which is hereby incorporated by reference in its entirety.
- the opacity of the mask can also vary in different regions of the mask.
- the opacity of the outer edge and/or the inner edge of the mask can be less than the central region of the mask.
- the opacity in different regions can transition abruptly or have a gradient transition. Additional examples of opacity transitions can be found in U.S. Pat. Nos. 5,662,706, 5,905,561 and 5,965,330, all of which are hereby incorporated by reference in their entirety.
- FIGS. 3 A- 3 C show another embodiment of a mask 2100 capable of increasing depth of focus of an eye of a patient with presbyopia.
- the mask 2100 can be flat (as in FIG. 2 B ) or curved (as in FIG. 2 A ).
- the mask 2100 can be similar to the masks hereinbefore described, except as described differently below.
- the mask 2100 can be made of the materials discussed herein, including those discussed above.
- the mask 2100 can be formed by any suitable process.
- the mask 2100 can be applied to and/or embedded in an IOL.
- the mask 2100 can include a plurality of holes 2120 .
- the lens body can extend at least partially through the holes, thereby creating a bond (e.g. material “bridge”) between the lens body on either side of the mask.
- a bond e.g. material “bridge”
- material “bridge” can be found in U.S. Publication No. 2011/0040376, filed Aug. 13, 2010, which is incorporated by reference herein in its entirety.
- the holes 2120 of the mask 2100 shown in FIG. 3 A can be located anywhere on the mask 2100 . In some embodiments, substantially all of the holes are in one or more regions of a mask.
- the holes 2120 of FIG. 3 A extend at least partially between the anterior surface 2108 and the posterior surface 2112 of the mask 2100 .
- each of the holes 2120 includes a hole entrance 2160 and a hole exit 2164 .
- the hole entrance 2160 is located adjacent to the anterior surface 2108 of the mask 2100 .
- the hole exit 2164 is located adjacent to the posterior surface 2112 of the mask 2100 .
- each of the holes 2120 extends the entire distance between the anterior surface 2108 and the posterior surface 2112 of the mask 2100 . Further details about possible hole patterns are described in U.S. Patent Publication No. 2012/0143325, filed Feb. 10, 2012, which is incorporated by reference herein in its entirety.
- FIG. 4 illustrates a graphical representation of the hole pattern of the mask 2100 .
- the mask 2100 can include an annular region near the outer periphery 2124 of the mask having no holes. In certain embodiments, there are no holes within 0.1 mm of the outer periphery 2124 of the mask 2100 .
- the holes in the mask serve at least two purposes: the holes provide some light transmission and, as just discussed with respect to FIGS. 3 A- 3 C , the holes create areas where the material of the implant body can extend through to create a material “bridge” that holds the mask in place.
- the holes through the mask can help to prevent delamination of the interface between the mask and the lens body. Delamination can occur during manipulation of the intraocular implant such as when the intraocular implant is folded or rolled and placed into a tube to be implanted into the patient.
- the lens body can extend through the holes, thereby creating a bond (e.g. material “bridge”) between the lens body on either side of the mask.
- Delamination can also be reduced by matching mechanical properties (e.g. elastic modulus) of the mask to the lens body.
- Another method to reduce delamination is to create a bond between the lens body and the mask.
- the lens body and the mask can have cross-linking bonds or van der Waals forces between them.
- the anterior surface of the mask has a mask surface area
- the light transmission structures (e.g., holes) in the mask have a total area on the anterior surface of the mask of about 1% to about 5% of the mask surface area.
- the holes can be made as small as possible.
- the Airy disc from each hole is larger the smaller the hole size, so the composite diffraction pattern produced by the pattern of holes becomes larger as well.
- the composite diffraction pattern spreads light over a larger portion of the retina, decreasing the local brightness of diffracted light and making diffraction artifacts less visible.
- Diffraction patterns produced by a pattern of holes also tends to have a chromatic component such that the diffraction halo tends to graduate in color radially. Varying the size of the holes produces this effect in multiple scales, which scrambles the color of the halo. This reduces color contrast in the halo, making it less noticeable.
- the outer diameter of the outer periphery of the mask can be varied. In certain embodiments, the outer diameter is selected to selectively allow an amount of light to pass to the retina of the eye.
- the pupil of the eye changes size in different lighting condition. In low light situations, the pupil of the eye enlarges to let more light into the eye.
- the outer diameter can be selected so that light does not pass outside the outer periphery of the mask in relatively high light conditions, and so that at least some light can pass outside the outer periphery of the mask in relatively low light conditions.
- the pupil size of patients often can vary; therefore, the outer diameter of the mask can be selected for a specific patient pupil size. For example, for patients with relatively small pupils, dim light may present more of a vision issue than for patients with larger pupils.
- a mask with more light transmission and/or a smaller outer diameter will increase light reaching the retina and improve vision in dim light situations. Conversely, for larger pupil patients, less light transmission and/or a larger outer diameter mask may improve low-contrast near vision and block more unfocused light.
- the masked IOLs of the present application give the surgeon flexibility to prescribe the appropriate combination of masked IOL features for particular patients.
- the center of the aperture of the mask is off-center to the center of the lens body.
- the intraocular lens can be rotated during the implantation procedure so that the optical center of the patient's eye can be aligned with the center of the aperture.
- the vision of the patient can be improved by aligning the optical center of the patient's eye with the aperture center.
- the mask 2100 can include an annular region near the outer periphery 2124 of the mask having no holes. In certain embodiments, there are no holes within 0.1 mm of the outer periphery 2124 of the mask 2100 .
- the mask can include an annular region around the inner periphery of the mask having no holes. In certain embodiments, there are no holes within 0.1 mm of the aperture 2128 .
- the holes 2120 each have the same diameter. In certain embodiments, the holes 2120 can include one or more different diameters. In some embodiments, the diameter of any single hole 2120 is at least about 0.01 mm and/or less than or equal to about 0.02 mm. In some embodiments, the diameter of the holes 2120 can vary within 0.001 mm of one or more of the following hole diameters: 0.010 mm, 0.013 mm, 0.016 mm, and/or 0.019 mm. In some embodiments, holes of different diameters are interspersed throughout at least a portion of the mask 2100 . In some embodiments, the holes are interspersed at irregular locations throughout at least a portion of the mask 2100 .
- the mask includes holes greater than about 7 microns in diameter (e.g., greater than a cross-sectional area of about 35 ⁇ m 2 ), and preferably greater than about 10 microns in diameter (e.g., greater than a cross-sectional area of about 75 ⁇ m 2 ). In certain embodiments, the mask includes holes greater than about 7 microns in diameter (e.g., greater than a cross-sectional area of about 35 ⁇ m 2 ) and less than about 20 microns in diameter (e.g., less than a cross-sectional area of about 320 ⁇ m 2 ).
- the mask includes holes less than about 50 microns in diameter (e.g., less than a cross-sectional area of about 2000 ⁇ m 2 . Holes with diameters less than 7 microns may not be large enough for lens material such as silicone or acrylic to enter and migrate to form a bridge. However, the viscosity of the lens material will determine whether the material will be able to migrate into the hole to form the bridge and a minimum cross-sectional area of the hole may be dependent on the material of the implant body. If the material of the implant body does not migrate into a hole, that hole may create a bubble that could interfere with the visual performance of the implant.
- lens material such as silicone or acrylic
- the mask includes randomly or pseudo-randomly placed holes across the mask.
- the mask can include holes with one of four hole diameters within the parameters provided above. There can be an equal number of holes with each hole diameter.
- An algorithm can be used to randomly or pseudo-randomly assign the variously sized holes to locations across the mask annulus.
- the rules for the randomization program can include (1) that there be no “collisions” of the holes (e.g., the holes have no contact with each other), (2) that no holes interfere with the inner and outer peripheral edges of the mask, and (3) that the holes are placed in such a way as to create substantial uniform density across the mask annulus.
- the rules for the randomization program may include one or more of these rules.
- the holes are interspersed at irregular locations throughout at least a portion of the mask 2100 .
- holes of different diameters are evenly interspersed throughout at least a portion of the mask 2100 .
- the mask 2100 can include a plurality of non-overlapping hole regions. The sum of the surface area of the plurality of non-overlapping hole regions can equal the total surface area of the entire hole region of the mask.
- each region of the plurality of regions can include a number of holes, each of the holes having a different diameter.
- the number of holes in each region can equal the number of different hole sizes in the entire hole region.
- an amount of open area within each hole region can be substantially the same.
- each hole region can include the same number of holes.
- any of the masks discussed herein can be formed of any suitable material, including, but not limited to, at least one of an open cell foam material, an expanded solid material, and/or a substantially opaque material.
- the material used to form the mask can have relatively high water content.
- the materials that can be used to form the body 2104 include polymers (e.g. PMMA, PVDF, polypropylene, polycarbonate, PEEK, polyethylene, polystyrene, PVC, polysulfone), hydrogels, metals, metal alloys, or carbon (e.g., graphene, pure carbon), but preferably acrylic copolymers or silicone.
- the durometer (type A) of the mask material can be less than or equal to about 100, for example, between about 25 and about 50, such as about 40.
- the percent elongation to break for the mask material can be between about 150 percent and about 600 percent, for example, within about 50 percent of each of about 200 percent, 250 percent, 300 percent, 350 percent, 400 percent, 450 percent, 500 percent, or about 550 percent.
- the elongation can be between about 150 percent and about 200 percent, such as about 175 percent.
- the elongation can be between about 500 percent and about 600 percent, such as about 550 percent.
- the tensile strength of the mask material can be less than or equal to 15 MPa, for example, within about 2 MPa of each of about 10 MPa, 8 MPa, 6 MPa, or 4 MPa.
- the modulus of elasticity of the mask material can be between about 0.5 MPa and about 2 MPa, for example, within about 0.25 MPa of about 0.75 MPa, 1.0 MPa, 1.25 MPa, 1.5 MPa, or 1.75 MPa.
- methods of manufacturing the IOL and methods of implanting the IOL can degrade optical performance of the IOL if the material properties of the IOL and the mask are not compatibly selected to withstand, for example, deformations (such as those resulting from swelling that may occur during chemical extractions or treatments), and temperature shifts.
- deformations such as those resulting from swelling that may occur during chemical extractions or treatments
- temperature shifts it can be desirable to select a mask material and a lens material having appropriate material properties to allow the device to revert to, or otherwise achieve, a desired optical performance even after suffering some type of deformation or temperature differential.
- the modulus of elasticity of the mask material can be within about 50 percent of the modulus of elasticity of the lens material. In some implementations, the modulus of elasticity of the mask material can be within about 45 percent of the modulus of elasticity of the lens material, or within about 30 percent of the modulus of elasticity of the lens material, or within about 20 percent of the modulus of elasticity of the lens material, or within about 10 percent of the modulus of elasticity of the lens material, or within about 5 percent of the modulus of elasticity of the lens material.
- the modulus of elasticity of the mask material can be greater than or equal to the modulus of elasticity of the lens material; while, in other implementations, the modulus of elasticity of the mask material can be less than the modulus of elasticity of the lens material. In some implementations, the modulus of elasticity of the mask material can be substantially the same as the modulus of elasticity of the lens material.
- the lens material is more voluminous than the mask material, the properties of the lens material will generally dominate. Thus, it can be particularly advantageous if the elasticity of the mask material is at least as great as that of the lens material in order to allow the embedded mask to react to deformation of the lens without becoming damaged or displaced.
- the mask material can be the same as the lens material.
- the mask material can include a hydrophilic or hydrophobic material.
- the mask material can include an acrylic copolymer or silicone.
- the lens material can include a hydrophilic or hydrophobic material.
- the lens material can include an acrylic copolymer or silicone.
- the modulus of elasticity of the lens material can be between about 0.50 MPa and about 1.5 MPa, for example, between about 0.75 MPa and about 1.25 MPa, such as within about 0.1 MPa of each of about 1.0 MPa, 1.1 MPa, 1.2 MPa, or 1.3 MPa.
- the percentage of elongation to break can be between about 150 percent and about 200 percent, for example, between about 160 percent and about 190 percent or between about 170 percent and about 180 percent, such as about 175 percent.
- the coefficient of thermal expansion of the mask material is substantially similar to that of the lens material. In this way, the mask material and the lens material respond to temperature differentials in similar ways to avoid the development of stress or strain between the mask and the IOL.
- the coefficient of thermal expansion of the mask material can be within about 30 percent of the coefficient of thermal expansion of the lens material, or within about 20 percent of the coefficient of thermal expansion of the lens material, or within about 10 percent of the coefficient of thermal expansion of the lens material, or within about 5 percent of the coefficient of thermal expansion of the lens material. In some implementations, the coefficient of thermal expansion of the mask material can be substantially the same as the coefficient of thermal expansion of the lens material.
- the mask material can be the same as the lens material.
- the mask material can include a hydrophilic or hydrophobic material.
- the mask material can include an acrylic copolymer or silicone.
- the lens material can include a hydrophilic or hydrophobic material.
- the mask material can include an acrylic copolymer or silicone.
- the method can include injecting the IOL through a small cartridge tip having an inside diameter of less than or equal to about 2.0 mm, for example, within about 0.2 mm of about 1.5 mm, preferably less than or equal to about 1.5 mm, such as between about 1.5 mm and about 1.25 mm or between about 1.25 mm and about 1.0 mm.
- the injection system can deliver the IOL through an incision having a chord length of less than or equal to about 2.4 mm.
- the IOL can be configured to transition between a pre-injection configuration (e.g., rolled up for implantation) and a post-injection configuration (expanded, in-situ shape).
- the pre-injection configuration can be substantially smaller than the post-injection configuration.
- the optical power of the IOL prior to injection can be within about 0.5 diopters, preferably within about 0.3 diopters, or within about 0.2 diopters, or within about 0.1 diopters, of the optical power of the IOL after injection.
- the IOL can expand when it is introduced into the body because of the difference between room and body temperature in the eye, e.g., in an anterior chamber of the eye.
- the temperature differential can be between about 5° C. and about 20° C., for example, between about 5° C. and about 10° C., between about 10° C. and 15° C., or between about 15° C. and about 20° C.
- the room temperature can be between about 18° C. and about 26° C.
- the temperature of the anterior chamber of the eye can be between about 18° C. (e.g., transiently during irrigation/aspiration) and about 37° C.
- the IOL can undergo the temperature differential without substantially changing optical performance.
- the optical power of the IOL at room temperature can be within about 0.15 diopters, such as within about 0.03 diopters of about 0.1 diopters, for example, about 0.13 diopters, of the optical power of the IOL at body temperature.
- the mask can be formed using a mask material alone or in combination with an opacification agent.
- the mask material can include any of the mask materials described herein, for example, silicone or an acrylic copolymer.
- the mask material can be combined with an opacification agent, such as carbon black, or any class 3 medical device material.
- the resulting mixture can be used to form a mask film having a thickness equal to the desired mask thickness.
- Techniques for forming the mask film can include allowing mask material to spread to a desired thickness by gravity or by spinning. Each mask can then be formed from the mask film using a stamp, sieve, die, laser, or other machine.
- the mask material can be formed into a tube (e.g., using an extrusion process), and masks having the desired thickness can be cut from the tube. Further mask materials and methods of making a mask are disclosed in U.S. Pub. No. 2011/0040376, filed Aug. 13, 2010, which is incorporated by reference herein in its entirety.
- the mask can be embedded within or applied to a lens body.
- the method can include pre-dosing a first lens forming mold portion with a first amount of lens material and positioning the mask on a positioning mold portion. Thereafter, the first lens forming mold portion and the positioning mold portion can be joined together, and the lens material can be at least partially cured. After partially curing the lens material, at least the first lens forming mold portion can be cooled to facilitate the separation of the mold portions without disrupting the position of the mask. Once the mold portions are separated, a second amount of lens material can be added to the first lens forming mold portion and/or a second lens forming mold portion, and the first lens forming mold portion and the second lens forming mold portion can be joined together.
- the first and the second amounts of lens material can be at least partially cured, for example, using a light cure.
- the final curing process can be carried out using thermal curing.
- the IOL can undergo chemical extraction to remove any impurities. Further details regarding this manufacturing method or alternatives can be found in U.S. patent application Ser. No. 13/830,889 and U.S. Publication No. 2014/0131905, both filed Mar. 14, 2013, which are incorporated by reference herein in their entireties.
- the intraocular lens can be manufactured using stereolithography to image the mask within the lens.
- the method can include providing a first amount of photoreactive lens material.
- the method can also include forming a first layer of the intraocular lens by curing the first amount of photoreactive lens material to form the desired shape.
- the method can include providing a second amount of photoreactive lens material over the cured first layer and forming a second layer of the intraocular lens by curing the second amount of photoreactive lens material to form the desired shape. This process can be repeated to additively form the lens.
- a mask can be imaged within the initial layers by activating dyes such as those described in U.S. Publication No.
- the manufacturing method can include an extraction process to remove impurities.
- the method can include a chemical extraction process.
- the IOL can undergo a volumetric increase of at least about 5%, sometimes at least about 10%.
- the optical power of the IOL before extraction can be within about 0.5 diopters, preferably within about 0.3 diopters, or within about 0.2 diopters, or within about 0.1 diopters, of the optical power of the IOL after extraction.
- Conditional language such as “can,” “could,” “might,” or “may,” unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements, and/or steps. Thus, such conditional language is not generally intended to imply that features, elements, and/or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without user input or prompting, whether these features, elements, and/or steps are included or are to be performed in any particular embodiment.
- the terms “approximately,” “about,” and “substantially” as used herein represent an amount close to the stated amount that still performs a desired function or achieves a desired result.
- the terms “approximately”, “about”, and “substantially” may refer to an amount that is within less than 10% of, within less than 5% of, within less than 1% of, within less than 0.1% of, and within less than 0.01% of the stated amount.
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Transplantation (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Manufacturing & Machinery (AREA)
- Mechanical Engineering (AREA)
- Physics & Mathematics (AREA)
- Electromagnetism (AREA)
- Prostheses (AREA)
Abstract
Description
- This application is a continuation of U.S. application Ser. No. 16/722,490, filed Dec. 20, 2019, which is a continuation of U.S. application Ser. No. 16/017,834, filed Jun. 25, 2018, now U.S. Pat. No. 10,548,717, which is a continuation of U.S. application Ser. No. 14/454,585, filed Aug. 7, 2014, now U.S. Pat. No. 10,004,593, which is a continuation-in-part of U.S. application Ser. No. 12/856,492, now U.S. Pat. No. 9,492,272, filed Aug. 13, 2010, titled “MASKED INTRAOCULAR IMPLANTS AND LENSES,” which claims priority benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 61/233,804, filed Aug. 13, 2009, titled “MASKED INTRAOCULAR IMPLANTS AND LENSES,” and U.S. Provisional Application No. 61/233,794, filed Aug. 13, 2009, titled “INTRAOCULAR IMPLANT WITH PRESBYOPIC CORRECTION,” each of which is hereby incorporated by reference in its entirety. This application also claims priority benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 61/863,833, filed Aug. 8, 2013, titled “INTRAOCULAR LENS WITH ELASTIC MASK,” which is hereby incorporated by reference in its entirety.
- This application relates generally to the field of intraocular devices. More particularly, this application is directed to intraocular implants and lenses (IOLs) with an aperture to increase depth of focus (e.g. “masked” intraocular lenses), and methods of making the same.
- The human eye functions to provide vision by transmitting and focusing light through a clear outer portion called the cornea, and further refining the focus of the image onto a retina by way of a crystalline lens. The quality of the focused image depends on many factors including the size and shape of the eye, and the transparency of the cornea and the lens.
- The optical power of the eye is determined by the optical power of the cornea and the crystalline lens. In a normal, healthy eye, sharp images of distant objects are formed on the retina (emmetropia). In many eyes, images of distant objects are either formed in front of the retina because the eye is abnormally long or the cornea is abnormally steep (myopia), or formed in back of the retina because the eye is abnormally short or the cornea is abnormally flat (hyperopia). The cornea also may be asymmetric or toric, resulting in an uncompensated cylindrical refractive error referred to as corneal astigmatism.
- Some people suffer from cataracts in which the crystalline lens undergoes a loss of transparency. In such cases, the crystalline lens can be removed and replaced with an intraocular lens (IOL). However, some intraocular lenses may still leave defects in a patient's non-distance eyesight.
- Certain aspects of this disclosure are directed toward an intraocular lens including a mask embedded within, or secured to, a lens body including a lens material. The mask can include an aperture for improving depth of focus. Further, the mask can include a mask material having a modulus of elasticity that is within about 30 percent of a modulus of elasticity of the lens material.
- Certain aspects of this disclosure are directed toward an intraocular lens including a mask embedded within, or secured to, a lens body including a lens material. The mask can include an aperture for improving depth of focus. Further, the mask can include a mask material having a coefficient of thermal expansion that is within about 30 percent of the coefficient of thermal expansion of the lens material. In some embodiments, the mask material has a coefficient of thermal expansion that is within about 20 percent, within about 10 percent, or within about 5 percent of the coefficient of thermal expansion of the lens material.
- In any of the above mentioned aspects, the intraocular lens can be configured such that a pre-injection optical power of the intraocular lens can be within about 0.5 diopters, preferably within about 0.3 diopters, or within about 0.2 diopters, or within about 0.1 diopters, of a post-injection optical power of the intraocular lens.
- In any of the above mentioned aspects, the modulus of elasticity of the mask material can be within about 20 percent of the modulus of elasticity of the lens material, or within about 10 percent of the modulus of elasticity of the lens material, or within about 5 percent greater than the modulus of elasticity of the lens material. In some embodiments, the modulus of elasticity of the mask material can be greater than or equal to the modulus of elasticity of the lens material. In some embodiments, the modulus of elasticity of the mask material can be less than the modulus of elasticity of the lens material.
- In any of the above mentioned aspects, the mask material can include silicone or acrylic.
- In any of the above mentioned aspects, the lens material and the mask material can include the same material.
- In any of the above mentioned aspects, the mask can include a plurality of holes characterized in that at least one of a hole size, shape, orientation, and spacing of the plurality of holes is varied to reduce the tendency of the holes to produce visible diffraction patterns.
- In any of the above mentioned aspects, the mask can include a thickness of less than or equal to about 200 microns, preferably less than or equal to about 100 microns. For example, the thickness can be at least about 4 microns and less than or equal to about 20 microns, or less than or equal to about 15 microns, or less than or equal to about 10 microns.
- In any of the above mentioned aspects, the lens body can include an outer diameter between about 3 mm and about 6 mm. Further, the lens body can be capable of insertion through an incision having a chord length of less than or equal to about 3.0 mm or less than or equal to about 2.4 mm.
- In any of the above mentioned aspects, the intraocular lens can be configured such that a room temperature optical power of the intraocular lens can be within about 0.15 diopters, such as within about 0.03 diopters of 0.1 diopters, for example, about 0.13 diopters, of a body temperature optical power of the intraocular lens.
- In any of the above mentioned aspects, the intraocular lens can undergo a temperature differential of about 10° C. without substantially affecting optical power.
- Certain aspects of this disclosure are directed toward a method of implanting an intraocular lens. The method can include creating an incision having a chord length of less than or equal to about 2.4 mm, and injecting an intraocular lens through the incision using an injector system.
- The injected intraocular lens can include a mask embedded within, or secured to, a lens body including a lens material. The mask can include an aperture for improving depth of focus. In some embodiments, the modulus of elasticity of the mask material can be within about 30 percent of the modulus of elasticity of the lens material, or within about 20 percent of the modulus of elasticity of the lens material, or within about 10 percent of the modulus of elasticity of the lens material, or within about 5 percent of the modulus of elasticity of the lens material. In some embodiments, the modulus of elasticity of the mask material can be greater than or equal to the modulus of elasticity of the lens material. In some embodiments, the modulus of elasticity of the mask material can be less than the modulus of elasticity of the lens material. The intraocular lens can further include any of the aspects of the intraocular lenses described above.
- Certain aspects of this disclosure are directed toward a method of implanting an intraocular lens. The method can include creating an incision, injecting an intraocular lens through the incision using an injector system, and introducing the intraocular lens to a temperature differential of at least about 10° C. without substantially affecting optical power.
- The injected intraocular lens can include a mask embedded within, or secured to, a lens body including a lens material. The mask can include an aperture for improving depth of focus. Further, the mask can include a material having a coefficient of thermal expansion that is within about 30 percent of a coefficient of thermal expansion of the lens material, within about 20 percent of a coefficient of thermal expansion of the lens material, within about 10 percent of a coefficient of thermal expansion of the lens material, or within about 5 percent of a coefficient of thermal expansion of the lens material. The intraocular lens can further include any of the aspects of the intraocular lenses described above.
- Certain aspects of this disclosure are directed toward a method of manufacturing an intraocular lens. The method can include forming a mask with an aperture for improving depth of focus from a mask material, inserting a lens material into a mold, and curing the lens material to form a lens body. The lens body can include the mask therein. The lens material can include a modulus of elasticity that is within about 30 percent of a modulus of elasticity of the mask material. The intraocular lens can further include any of the aspects of the intraocular lenses described above.
- Certain aspects of this disclosure are directed toward a method of manufacturing an intraocular lens. The method can include forming a mask with an aperture for improving depth of focus from a mask material, inserting a lens material into a mold, and curing the lens material to form a lens body. The lens body can include the mask therein. Further, the lens material can include a coefficient of thermal expansion that is within about 30 percent of a coefficient of thermal expansion of the mask material. The intraocular lens can further include any of the aspects of the intraocular lenses described above.
- In any of the above mentioned methods of manufacturing, the method can include forming the mask by spin-casting the mask material, stamping the mask material, printing the mask material, or extruding the mask material.
- In any of the above mentioned methods of manufacturing, the method can include, after curing the lens material, chemically extracting residual lens material.
- Any feature, structure, or step disclosed herein can be replaced with or combined with any other feature, structure, or step disclosed herein, or omitted. Further, for purposes of summarizing the disclosure, certain aspects, advantages and features of the inventions have been described herein. It is to be understood that not necessarily any or all such advantages are achieved in accordance with any particular embodiment of the inventions disclosed herein. No aspects of this disclosure are essential or indispensable.
- Various embodiments are depicted in the accompanying drawings for illustrative purposes, and should in no way be interpreted as limiting the scope of the embodiments. Furthermore, various features of different disclosed embodiments can be combined to form additional embodiments, which are part of this disclosure.
-
FIG. 1A illustrates a top view of an example embodiment of an intraocular lens having an embedded mask for improving depth of focus. -
FIG. 1B illustrates a cross-sectional view of the intraocular lens ofFIG. 1A taken along line 1B-1B. -
FIG. 2A is a perspective view of one embodiment of a mask configured to increase depth of focus. -
FIG. 2B is a perspective view of an embodiment of a substantially flat mask configured to increase depth of focus. -
FIG. 3A is a top view of another embodiment of a mask configured to increase depth of focus. -
FIG. 3B is an enlarged view of a portion of the view ofFIG. 3A . -
FIG. 3C is a cross-sectional view of the mask ofFIG. 3B taken alongline 3C-3C. -
FIG. 4 is a graphical representation of one arrangement of holes of a plurality of holes that may be formed in the mask. - As discussed herein, people who undergo intraocular lens (IOL) implantation surgery may still suffer from defects in their non-distance eyesight (e.g., presbyopia). One technique for treating such defects is by including a mask within the IOL that increases the patient's depth of focus. The intraocular implants of the embodiments described herein include a mask adapted to provide a small aperture for light to pass through to the retina to increase depth of focus. The light rays that pass through the mask within the IOL converge at substantially a single focal point on the retina, while the light rays that would not converge at the single point on the retina are blocked by the mask.
- Several alternatives to fixed-focus IOLs have been developed for improving non-distance eyesight, including multifocal IOLs and accommodating IOLs. These devices attempt to provide the ability to see clearly at both near and far distances. However, accommodating IOLs can be complex and some multifocal IOLs do not perform well at intermediate distances and cause glare, halos, and night vision difficulties associated with the presence of unfocused light. This limitation can force designers of multifocal optics to choose how much of the light is directed to each focal point, and to deal with the effects of the unfocused light that is always present in any image. In order to maximize acuity at the important distances of infinity (e.g., >6M) and 40 cm (e.g., a normal reading distance), it is typical to provide little or no light focused at an intermediate distance, and as a result, visual acuity at these distances is poor. With a mask that includes an aperture to increase depth-of-focus, however, the intermediate vision of a patient can be improved significantly. For example, the defocus blur associated with the aperture can be less at intermediate distances than at near.
-
FIGS. 1A-B illustrate an example embodiment of an intraocular lens having an embeddedmask 1008 for increasing depth of focus. Theintraocular lens 1000 can includehaptics 1004 for positioning the lens within the eye. The cross-sectional thickness of the lens body 1002 is generally dependent on the optical power of theintraocular lens 1000 and the material of the lens body 1002. In particular, the central region of the lens body 1002 is generally the thickest section of theintraocular lens 1000 with a central regioncross-sectional thickness 1006. Methods for reducing the thickness of the intraocular lens are described in U.S. Pub. No. 2011/0040376, filed Aug. 13, 2010, which is incorporated herein by reference in its entirety. Any of the teachings of this prior publication can also be applied to the devices and methods in the present disclosure. - One method of implanting the
IOL 1000 can include inserting the IOL through a small incision in the eye. TheIOL 1000 can be inserted into the eye using an injector system. The injector system can include a cartridge tip for housing theIOL 1000. The size of the hole in the cartridge tip through which theIOL 1000 is injected is typically smaller than the size of the IOL. Thus, theIOL 1000 is deformed (e.g., stretched) when passing through the tip during the injection process. TheIOL 1000 can be made of a resilient material such that it can revert back to its pre-injection shape after passing through the cartridge tip. When using this method, the size of the incision is generally dependent on the size of the cartridge tip. Typically, smaller surgical incisions are associated with better surgical outcomes. - However, the size of the cartridge tip and incision can be limited by the material properties of the lens body. This problem can be further complicated by the embedded
mask 1008 within theIOL 1000. For example, as theIOL 1000 is pushed through the cartridge tip, the extrusion forces can not only stretch or otherwise deform the IOL but also the embeddedmask 1008. In addition, the location of the embeddedmask 1008 within theIOL 1000 can be displaced (e.g., the embedded mask can become transversely de-centered and/or longitudinally biased to either side of the desired longitudinal depth of the embedded mask within the IOL). - After releasing the
IOL 1000 from the cartridge tip, it is desirable that theIOL 1000 and the embeddedmask 1008 achieve a target post-injection optical performance specification (e.g., optical power, presbyopia correction, etc.). For example, it may be desirable for the post-injection optical performance to substantially match the pre-injection optical performance. Thus, in some embodiments, theIOL 1000 and the embeddedmask 1008 have material properties (e.g., elasticity) that allow them to revert back to their pre-injection shapes, and, in the case of the embedded mask, its pre-injection location within the IOL. - Similar issues are pertinent to the method of manufacturing the
IOL 1000 with the embeddedmask 1008. IOL manufacturing processes can involve steps where the IOL swells, undergoes temperature differentials, etc. The mask can be deformed if it does not have sufficient elasticity or a compatible coefficient of thermal expansion when compared to the IOL material. - Some methods of manufacturing the
IOL 1000 can include chemically extracting impurities from the IOL. For example, the chemical extraction process can be used to remove residual lens material monomer. The chemical extraction process can include immersing the IOL in a chemical (e.g., hexane, benzene, or alcohol) over a pre-determined period of time and a particular temperature profile. In some instances, during the chemical extraction process, the lens body can undergo a volumetric increase of at least about 10%. If the material properties of the mask material differ too much from the material properties of the lens material, then themask 1008 can undergo deformation and/or displacement, thus degrading the optical performance of the IOL. This can occur if, for example, the modulus of elasticity of the mask material is much different than the modulus of elasticity of the lens material. - It can be particularly difficult to maintain the desired optical performance through deformations and temperature differentials when the
mask 1008 and the lens body exhibit incompatible material properties (e.g. modulus of elasticity or coefficient of thermal expansion). If one or both of the mask material and lens body material do not exhibit appropriate material properties, themask 1008 and/or lens body can be permanently deformed or, in the case of the embedded mask, biased to an undesired location within the IOL, during deformations (such as those that may occur during chemical extractions), and/or temperature shifts. This can affect optical performance (e.g., optical power or presbyopia correction). For example, if the lens body exhibits greater elasticity than the mask material, then, after injection, themask 1008 can be deformed and degrade the optical performance of theIOL 1000. As another example, if the coefficients of expansion of the lens material and the mask material are too different, when the IOL transitions from room temperature (e.g., about 20° C.) to body temperature (e.g., about 35-37° C.), the resulting stress and strain can cause the mask to be deformed and degrade the optical performance of the IOL. - Provided below are examples of IOLs with embedded masks that are designed to overcome the issues described above. In some implementations, the IOLs (e.g., 1000) with embedded masks (e.g., 1008) that are described herein include substantially the same optical characteristics pre-injection and post-injection. Masks
-
FIG. 2A illustrates one embodiment of amask 2034 a. Themask 2034 a can include anannular region 2036 a surrounding an aperture 2038 a substantially centrally located on themask 2034 a. The aperture 2038 a can be generally located around a central axis 2039 a, referred to herein as the optical axis of themask 2034 a. The aperture 2038 a can be in the shape of a circle.FIG. 2B illustrates another embodiment of amask 2034 b similar to themask 2034 a illustrated inFIG. 2A . Theannular region 2036 a of themask 2034 a ofFIG. 2A has a curvature from the outer periphery to the inner periphery of theannular region 2036 a, while theannular region 2036 b of themask 2034 b ofFIG. 2B can be substantially flat (as shown inFIG. 1B ). Although the examples provided herein are generally discussed in connection with themask 2034 b, any of the examples can include themask 2034 a. In addition, a variety of variations of masks that can be positioned on or within the implant body are discussed herein, and are also described in U.S. Patent Publication No. 2012/0143325, filed Feb. 10, 2012, which is incorporated by reference herein in its entirety. Any of the teachings of this prior publication can also be applied to the devices and methods in the present disclosure. - The
mask 2034 b can have dimensions adapted to function with the implant body to improve a patient's vision. For example, the thickness of themask 2034 b can vary depending on the location of themask 2034 b relative to the implant body. For example, if themask 2034 b is embedded within the implant body, themask 2034 b can have a thickness greater than zero and less than the thickness of the implant body. Alternatively, if the mask is coupled to a surface of the implant body, themask 2034 b may have a thickness no greater than necessary to have the desired opacity so that the mask does not add additional thickness to the intraocular lens. - In some implementations, the
mask 2034 b can have a substantially constant thickness. However, in other implementations, the thickness of the mask may vary between the inner periphery (near theaperture 2038 b) and the outer periphery. - In general, the thickness of the
mask 2034 b can be less than or equal to about 200 microns, or less than or equal to about 100 microns, but preferably between about 1 micron and about 20 microns. For example, the thickness of themask 2034 b can be within the range from about 1 micron to about 40 microns, in the range from about 5 microns to about 20 microns, or otherwise. In some embodiments, themask 2034 b can include a thickness of at least about 5 microns and/or less than or equal to about 20 microns. In some embodiments, themask 2034 b can include a thickness of at least about 5 microns and/or less than or equal to about 15 microns. In certain embodiments, the thickness can be within two microns of about 15 microns, about 10 microns, about 8 microns, about 5 microns, or otherwise. In other embodiments, however, the mask may be a bulk mask and its width may extend across much of the thickness of the lens (e.g., the width of the mask may be at least about 80 percent of the thickness of the implant body or at least about 90 percent of the thickness of the implant body). - The
mask 2034 b can be symmetrical, e.g., symmetrical about amask axis 2039 b. In some embodiments, the outer periphery of themask 2034 b can be circular. Themask 2034 b in general can have an outer diameter of at least about 3 mm and/or less than about 6 mm. In some embodiments, themask 2034 b can be circular and can include a diameter of at least about 3 mm and/or less than or equal to about 4 mm. In some embodiments, themask 2034 b can be circular and can include a diameter within a range of 0.2 mm of about 3.2 mm. - In some embodiments, the
aperture 2038 b can be substantially circular and can be substantially centered in themask 2034 b. The size of theaperture 2038 b can be any size that is effective to increase the depth of focus of an eye of a patient with presbyopia. In particular, the size of theaperture 2038 b can be dependent on the location of the mask within the eye (e.g., distance from the retina). In some embodiments, theaperture 2038 b can have a diameter of at least about 0.85 mm and/or less than or equal to about 2.2 mm. In certain embodiments, the diameter of theaperture 2038 b is less than or equal to about 2 mm. In some embodiments, the diameter of theaperture 2038 b is at least about 1.1 mm and/or less than or equal to about 1.6 mm. In some embodiments, the diameter of theaperture 2038b is at least about 1.3 mm and/or less than or equal to about 1.4 mm. - The
aperture 2038 b can transmit substantially all incident light along themask axis 2039 b. Theannular region 2036 b can substantially prevent transmission of incident light thereon. Theaperture 2038 b can be a through-hole in theannular region 2036 b or a substantially light transmissive (e.g., transparent) portion thereof. Theaperture 2038 b of themask 2034 b can be generally defined within the outer periphery of themask 2034 b. - The
annular region 2036 b can at least partially prevent transmission of visible light through themask 2034 b. For example, in some embodiments, theannular region 2036 b can prevent transmission of substantially all or at least a portion of the spectrum of the incident visible light. In some embodiments, theannular region 2036 b can prevent transmission of substantially all visible light, e.g., radiant energy in the electromagnetic spectrum that is visible to the human eye. Theannular region 2036 b can substantially prevent transmission of radiant energy outside the range visible to humans in some embodiments. - Preventing transmission of light through the
annular region 2036 b can decrease the amount of light that reaches the retina and the fovea that would not converge at the retina and fovea to form a sharp image. As discussed above, the size of theaperture 2038 b is such that the light transmitted therethrough generally converges at the retina or fovea. Accordingly, a much sharper image can be presented to the retina than would otherwise be the case without themask 2034 b. - In some embodiments, the
annular region 2036 b can prevent transmission of at least about 90 percent of incident light. In some embodiments, theannular region 2036 b can prevent transmission of at least about 92 percent, at least about 95 percent, or at least about 98 percent of all incident light. Theannular region 2036 b of themask 2034 b can be substantially opaque to prevent the transmission of light. - In some embodiments, the
annular region 2036 b can transmit no more than about 5% of incident visible light. In some embodiments, theannular region 2036 b can transmit no more than about 3 percent of incident visible light. In some embodiments, theannular region 2036 b can transmit no more than about 2 percent of incident visible light. In some embodiments, at least a portion of theannular region 2036 b can be opaque to more than 99 percent of the light incident thereon. - As discussed above, the
annular region 2036 b can prevent at least partial transmission of light without absorbing the incident light. For example, themask 2034 b can be reflective or can interact with the light in a more complex manner, as discussed in U.S. Pat. No. 6,554,424, issued Apr. 29, 2003, which is hereby incorporated by reference in its entirety. - The
annular region 2036 b can be at least partially opaque or can be completely opaque. The degree of opacity of theannular region 2036 b can prevent at least some or substantially all light from being transmitted through themask 2034 b. Opacity of theannular region 2036 b can be achieved in any of several different ways. For example, the material used to makemask 2034 b can be naturally opaque. As another example, the material used to make themask 2034 b can be substantially clear, but treated with a dye or other pigmentation agent to renderregion 2036 b substantially or completely opaque. In certain embodiments, the mask can include carbon black. In yet another example, the surface of themask 2034 b can be treated physically or chemically (such as by etching) to alter the refractive and transmissive properties of themask 2034 b and make it less transmissive to light. - In some embodiments, a photochromic material can be used as the mask or in addition to mask. Under bright light conditions, the photochromic material can darken thereby creating a mask and enhancing near vision. Under dim light conditions, the photochromic material can lighten, which allows more light to pass through to the retina. In certain embodiments, under dim light conditions, the photochromic material lightens to expose an optic of the intraocular implant. Further photochromic material details are disclosed in U.S. Patent Publication No. 2013/0268071, filed Nov. 30, 2012, which is hereby incorporated by reference in its entirety.
- The mask can transition between different degrees of opacity. For example, at least a portion of the mask can transition between at least a first degree of opacity and a second degree of opacity. Further details are disclosed in U.S. application Ser. No. 13/830,889, filed Mar. 14, 2013, which is hereby incorporated by reference in its entirety.
- In some embodiments, the opacity of the mask can also vary in different regions of the mask. For example, the opacity of the outer edge and/or the inner edge of the mask can be less than the central region of the mask. The opacity in different regions can transition abruptly or have a gradient transition. Additional examples of opacity transitions can be found in U.S. Pat. Nos. 5,662,706, 5,905,561 and 5,965,330, all of which are hereby incorporated by reference in their entirety.
-
FIGS. 3A-3C show another embodiment of amask 2100 capable of increasing depth of focus of an eye of a patient with presbyopia. Themask 2100 can be flat (as inFIG. 2B ) or curved (as inFIG. 2A ). Themask 2100 can be similar to the masks hereinbefore described, except as described differently below. Themask 2100 can be made of the materials discussed herein, including those discussed above. In addition, themask 2100 can be formed by any suitable process. Themask 2100 can be applied to and/or embedded in an IOL. - The
mask 2100 can include a plurality ofholes 2120. When themask 2100 is embedded in the lens body, the lens body can extend at least partially through the holes, thereby creating a bond (e.g. material “bridge”) between the lens body on either side of the mask. Further disclosure regarding the material “bridge” can be found in U.S. Publication No. 2011/0040376, filed Aug. 13, 2010, which is incorporated by reference herein in its entirety. - The
holes 2120 of themask 2100 shown inFIG. 3A can be located anywhere on themask 2100. In some embodiments, substantially all of the holes are in one or more regions of a mask. Theholes 2120 ofFIG. 3A extend at least partially between theanterior surface 2108 and theposterior surface 2112 of themask 2100. In some embodiments, each of theholes 2120 includes ahole entrance 2160 and ahole exit 2164. Thehole entrance 2160 is located adjacent to theanterior surface 2108 of themask 2100. Thehole exit 2164 is located adjacent to theposterior surface 2112 of themask 2100. In some embodiments, each of theholes 2120 extends the entire distance between theanterior surface 2108 and theposterior surface 2112 of themask 2100. Further details about possible hole patterns are described in U.S. Patent Publication No. 2012/0143325, filed Feb. 10, 2012, which is incorporated by reference herein in its entirety. -
FIG. 4 illustrates a graphical representation of the hole pattern of themask 2100. In some embodiments, themask 2100 can include an annular region near theouter periphery 2124 of the mask having no holes. In certain embodiments, there are no holes within 0.1 mm of theouter periphery 2124 of themask 2100. - The holes in the mask serve at least two purposes: the holes provide some light transmission and, as just discussed with respect to
FIGS. 3A-3C , the holes create areas where the material of the implant body can extend through to create a material “bridge” that holds the mask in place. Advantageously, if the mask is in a position between the posterior and anterior surfaces of a lens body, the holes through the mask can help to prevent delamination of the interface between the mask and the lens body. Delamination can occur during manipulation of the intraocular implant such as when the intraocular implant is folded or rolled and placed into a tube to be implanted into the patient. The lens body can extend through the holes, thereby creating a bond (e.g. material “bridge”) between the lens body on either side of the mask. Delamination can also be reduced by matching mechanical properties (e.g. elastic modulus) of the mask to the lens body. Another method to reduce delamination is to create a bond between the lens body and the mask. For example, the lens body and the mask can have cross-linking bonds or van der Waals forces between them. - It can be desirable to decrease or minimize the total amount of light that passes through the mask in order to increase or maximize near image contrast. Delamination can be prevented with a relatively small total area of the mask having holes for “bridges”. For example, an area of about 3% of the mask can include holes which can balance increasing or maximizing mechanical strength and reducing or minimizing optical effects of the holes. In certain embodiments, the anterior surface of the mask has a mask surface area, and the light transmission structures (e.g., holes) in the mask have a total area on the anterior surface of the mask of about 1% to about 5% of the mask surface area. To limit the impact of diffraction of light passing through the holes of the mask, the holes can be made as small as possible. The Airy disc from each hole is larger the smaller the hole size, so the composite diffraction pattern produced by the pattern of holes becomes larger as well. The composite diffraction pattern spreads light over a larger portion of the retina, decreasing the local brightness of diffracted light and making diffraction artifacts less visible. Diffraction patterns produced by a pattern of holes also tends to have a chromatic component such that the diffraction halo tends to graduate in color radially. Varying the size of the holes produces this effect in multiple scales, which scrambles the color of the halo. This reduces color contrast in the halo, making it less noticeable.
- The outer diameter of the outer periphery of the mask can be varied. In certain embodiments, the outer diameter is selected to selectively allow an amount of light to pass to the retina of the eye. The pupil of the eye changes size in different lighting condition. In low light situations, the pupil of the eye enlarges to let more light into the eye. The outer diameter can be selected so that light does not pass outside the outer periphery of the mask in relatively high light conditions, and so that at least some light can pass outside the outer periphery of the mask in relatively low light conditions. The pupil size of patients often can vary; therefore, the outer diameter of the mask can be selected for a specific patient pupil size. For example, for patients with relatively small pupils, dim light may present more of a vision issue than for patients with larger pupils. For smaller-pupil patients, a mask with more light transmission and/or a smaller outer diameter will increase light reaching the retina and improve vision in dim light situations. Conversely, for larger pupil patients, less light transmission and/or a larger outer diameter mask may improve low-contrast near vision and block more unfocused light. The masked IOLs of the present application give the surgeon flexibility to prescribe the appropriate combination of masked IOL features for particular patients.
- In certain embodiments, the center of the aperture of the mask is off-center to the center of the lens body. By having an aperture off-center to the optical center of the lens body, the intraocular lens can be rotated during the implantation procedure so that the optical center of the patient's eye can be aligned with the center of the aperture. The vision of the patient can be improved by aligning the optical center of the patient's eye with the aperture center.
- In some embodiments, the
mask 2100 can include an annular region near theouter periphery 2124 of the mask having no holes. In certain embodiments, there are no holes within 0.1 mm of theouter periphery 2124 of themask 2100. - In some embodiments, the mask can include an annular region around the inner periphery of the mask having no holes. In certain embodiments, there are no holes within 0.1 mm of the
aperture 2128. - In some embodiments, the
holes 2120 each have the same diameter. In certain embodiments, theholes 2120 can include one or more different diameters. In some embodiments, the diameter of anysingle hole 2120 is at least about 0.01 mm and/or less than or equal to about 0.02 mm. In some embodiments, the diameter of theholes 2120 can vary within 0.001 mm of one or more of the following hole diameters: 0.010 mm, 0.013 mm, 0.016 mm, and/or 0.019 mm. In some embodiments, holes of different diameters are interspersed throughout at least a portion of themask 2100. In some embodiments, the holes are interspersed at irregular locations throughout at least a portion of themask 2100. - In certain embodiments, the mask includes holes greater than about 7 microns in diameter (e.g., greater than a cross-sectional area of about 35 μm2), and preferably greater than about 10 microns in diameter (e.g., greater than a cross-sectional area of about 75 μm2). In certain embodiments, the mask includes holes greater than about 7 microns in diameter (e.g., greater than a cross-sectional area of about 35 μm2) and less than about 20 microns in diameter (e.g., less than a cross-sectional area of about 320 μm2). In further embodiments, the mask includes holes less than about 50 microns in diameter (e.g., less than a cross-sectional area of about 2000 μm2. Holes with diameters less than 7 microns may not be large enough for lens material such as silicone or acrylic to enter and migrate to form a bridge. However, the viscosity of the lens material will determine whether the material will be able to migrate into the hole to form the bridge and a minimum cross-sectional area of the hole may be dependent on the material of the implant body. If the material of the implant body does not migrate into a hole, that hole may create a bubble that could interfere with the visual performance of the implant.
- In a certain embodiment, the mask includes randomly or pseudo-randomly placed holes across the mask. The mask can include holes with one of four hole diameters within the parameters provided above. There can be an equal number of holes with each hole diameter. An algorithm can be used to randomly or pseudo-randomly assign the variously sized holes to locations across the mask annulus. The rules for the randomization program can include (1) that there be no “collisions” of the holes (e.g., the holes have no contact with each other), (2) that no holes interfere with the inner and outer peripheral edges of the mask, and (3) that the holes are placed in such a way as to create substantial uniform density across the mask annulus. For example, the rules for the randomization program may include one or more of these rules.
- In some embodiments there are at least about 1000 holes and/or less than or equal to about 2000 holes. In some embodiments, there are at least about 1000 holes and/or less than or equal to about 1100 holes. In some embodiments, the number of holes is within ten holes of about 1040 holes. In some embodiments, there are an equal number of holes of each diameter. In some embodiments, the number of holes having each diameter is different.
- In some embodiments, the holes are interspersed at irregular locations throughout at least a portion of the
mask 2100. In some embodiments, holes of different diameters are evenly interspersed throughout at least a portion of themask 2100. For example, themask 2100 can include a plurality of non-overlapping hole regions. The sum of the surface area of the plurality of non-overlapping hole regions can equal the total surface area of the entire hole region of the mask. In some implementations, each region of the plurality of regions can include a number of holes, each of the holes having a different diameter. In some implementations, the number of holes in each region can equal the number of different hole sizes in the entire hole region. In some implementations, an amount of open area within each hole region can be substantially the same. In some implementations, each hole region can include the same number of holes. - Any of the masks discussed herein can be formed of any suitable material, including, but not limited to, at least one of an open cell foam material, an expanded solid material, and/or a substantially opaque material. In some embodiments, the material used to form the mask can have relatively high water content. In some embodiments, the materials that can be used to form the
body 2104 include polymers (e.g. PMMA, PVDF, polypropylene, polycarbonate, PEEK, polyethylene, polystyrene, PVC, polysulfone), hydrogels, metals, metal alloys, or carbon (e.g., graphene, pure carbon), but preferably acrylic copolymers or silicone. - In some embodiments, the durometer (type A) of the mask material can be less than or equal to about 100, for example, between about 25 and about 50, such as about 40. In some embodiments, the percent elongation to break for the mask material can be between about 150 percent and about 600 percent, for example, within about 50 percent of each of about 200 percent, 250 percent, 300 percent, 350 percent, 400 percent, 450 percent, 500 percent, or about 550 percent. In some instances, the elongation can be between about 150 percent and about 200 percent, such as about 175 percent. In some instances, the elongation can be between about 500 percent and about 600 percent, such as about 550 percent. In some embodiments, the tensile strength of the mask material can be less than or equal to 15 MPa, for example, within about 2 MPa of each of about 10 MPa, 8 MPa, 6 MPa, or 4 MPa. In some embodiments, the modulus of elasticity of the mask material can be between about 0.5 MPa and about 2 MPa, for example, within about 0.25 MPa of about 0.75 MPa, 1.0 MPa, 1.25 MPa, 1.5 MPa, or 1.75 MPa.
- As described above, methods of manufacturing the IOL and methods of implanting the IOL can degrade optical performance of the IOL if the material properties of the IOL and the mask are not compatibly selected to withstand, for example, deformations (such as those resulting from swelling that may occur during chemical extractions or treatments), and temperature shifts. As such, it can be desirable to select a mask material and a lens material having appropriate material properties to allow the device to revert to, or otherwise achieve, a desired optical performance even after suffering some type of deformation or temperature differential.
- In some implementations, the modulus of elasticity of the mask material can be within about 50 percent of the modulus of elasticity of the lens material. In some implementations, the modulus of elasticity of the mask material can be within about 45 percent of the modulus of elasticity of the lens material, or within about 30 percent of the modulus of elasticity of the lens material, or within about 20 percent of the modulus of elasticity of the lens material, or within about 10 percent of the modulus of elasticity of the lens material, or within about 5 percent of the modulus of elasticity of the lens material. In some implementations, the modulus of elasticity of the mask material can be greater than or equal to the modulus of elasticity of the lens material; while, in other implementations, the modulus of elasticity of the mask material can be less than the modulus of elasticity of the lens material. In some implementations, the modulus of elasticity of the mask material can be substantially the same as the modulus of elasticity of the lens material.
- Since the lens material is more voluminous than the mask material, the properties of the lens material will generally dominate. Thus, it can be particularly advantageous if the elasticity of the mask material is at least as great as that of the lens material in order to allow the embedded mask to react to deformation of the lens without becoming damaged or displaced.
- In some implementations, the mask material can be the same as the lens material. In some implementations, the mask material can include a hydrophilic or hydrophobic material. In some implementations, the mask material can include an acrylic copolymer or silicone.
- In some embodiments, the lens material can include a hydrophilic or hydrophobic material. In some implementations, the lens material can include an acrylic copolymer or silicone. The modulus of elasticity of the lens material can be between about 0.50 MPa and about 1.5 MPa, for example, between about 0.75 MPa and about 1.25 MPa, such as within about 0.1 MPa of each of about 1.0 MPa, 1.1 MPa, 1.2 MPa, or 1.3 MPa. The percentage of elongation to break can be between about 150 percent and about 200 percent, for example, between about 160 percent and about 190 percent or between about 170 percent and about 180 percent, such as about 175 percent.
- In some implementations, the coefficient of thermal expansion of the mask material is substantially similar to that of the lens material. In this way, the mask material and the lens material respond to temperature differentials in similar ways to avoid the development of stress or strain between the mask and the IOL. In some implementations, the coefficient of thermal expansion of the mask material can be within about 30 percent of the coefficient of thermal expansion of the lens material, or within about 20 percent of the coefficient of thermal expansion of the lens material, or within about 10 percent of the coefficient of thermal expansion of the lens material, or within about 5 percent of the coefficient of thermal expansion of the lens material. In some implementations, the coefficient of thermal expansion of the mask material can be substantially the same as the coefficient of thermal expansion of the lens material.
- In some implementations, the mask material can be the same as the lens material. In some implementations, the mask material can include a hydrophilic or hydrophobic material. In some implementations, the mask material can include an acrylic copolymer or silicone.
- In some implementations, the lens material can include a hydrophilic or hydrophobic material. In some implementations, the mask material can include an acrylic copolymer or silicone.
- Any of the IOLs described herein can be implanted using an injection system. The method can include injecting the IOL through a small cartridge tip having an inside diameter of less than or equal to about 2.0 mm, for example, within about 0.2 mm of about 1.5 mm, preferably less than or equal to about 1.5 mm, such as between about 1.5 mm and about 1.25 mm or between about 1.25 mm and about 1.0 mm. The injection system can deliver the IOL through an incision having a chord length of less than or equal to about 2.4 mm. The IOL can be configured to transition between a pre-injection configuration (e.g., rolled up for implantation) and a post-injection configuration (expanded, in-situ shape). The pre-injection configuration can be substantially smaller than the post-injection configuration.
- In some implementations, it can be desirable for the IOL to transition between the pre-injection configuration and the post-configuration without substantially changing optical performance. For example, the optical power of the IOL prior to injection can be within about 0.5 diopters, preferably within about 0.3 diopters, or within about 0.2 diopters, or within about 0.1 diopters, of the optical power of the IOL after injection.
- As mentioned above, the IOL can expand when it is introduced into the body because of the difference between room and body temperature in the eye, e.g., in an anterior chamber of the eye. In some implementations, the temperature differential can be between about 5° C. and about 20° C., for example, between about 5° C. and about 10° C., between about 10° C. and 15° C., or between about 15° C. and about 20° C. The room temperature can be between about 18° C. and about 26° C., and the temperature of the anterior chamber of the eye can be between about 18° C. (e.g., transiently during irrigation/aspiration) and about 37° C.
- In some implementations, it can be desirable for the IOL to undergo the temperature differential without substantially changing optical performance. For example, the optical power of the IOL at room temperature can be within about 0.15 diopters, such as within about 0.03 diopters of about 0.1 diopters, for example, about 0.13 diopters, of the optical power of the IOL at body temperature.
- Various techniques can be used for forming the mask. In some embodiments, the mask can be formed using a mask material alone or in combination with an opacification agent. The mask material can include any of the mask materials described herein, for example, silicone or an acrylic copolymer. In some implementations, the mask material can be combined with an opacification agent, such as carbon black, or any
class 3 medical device material. - In some embodiments, the resulting mixture can be used to form a mask film having a thickness equal to the desired mask thickness. Techniques for forming the mask film can include allowing mask material to spread to a desired thickness by gravity or by spinning. Each mask can then be formed from the mask film using a stamp, sieve, die, laser, or other machine. In an alternative technique, the mask material can be formed into a tube (e.g., using an extrusion process), and masks having the desired thickness can be cut from the tube. Further mask materials and methods of making a mask are disclosed in U.S. Pub. No. 2011/0040376, filed Aug. 13, 2010, which is incorporated by reference herein in its entirety.
- After forming the mask, the mask can be embedded within or applied to a lens body. For example, the method can include pre-dosing a first lens forming mold portion with a first amount of lens material and positioning the mask on a positioning mold portion. Thereafter, the first lens forming mold portion and the positioning mold portion can be joined together, and the lens material can be at least partially cured. After partially curing the lens material, at least the first lens forming mold portion can be cooled to facilitate the separation of the mold portions without disrupting the position of the mask. Once the mold portions are separated, a second amount of lens material can be added to the first lens forming mold portion and/or a second lens forming mold portion, and the first lens forming mold portion and the second lens forming mold portion can be joined together. In this configuration, the first and the second amounts of lens material can be at least partially cured, for example, using a light cure. Finally, the final curing process can be carried out using thermal curing. In some implementations, depending on the mask and lens materials, the IOL can undergo chemical extraction to remove any impurities. Further details regarding this manufacturing method or alternatives can be found in U.S. patent application Ser. No. 13/830,889 and U.S. Publication No. 2014/0131905, both filed Mar. 14, 2013, which are incorporated by reference herein in their entireties.
- Alternatively, the intraocular lens can be manufactured using stereolithography to image the mask within the lens. The method can include providing a first amount of photoreactive lens material. Next, the method can also include forming a first layer of the intraocular lens by curing the first amount of photoreactive lens material to form the desired shape. Thereafter, the method can include providing a second amount of photoreactive lens material over the cured first layer and forming a second layer of the intraocular lens by curing the second amount of photoreactive lens material to form the desired shape. This process can be repeated to additively form the lens. After one or more initial layers of the lens have been formed, a mask can be imaged within the initial layers by activating dyes such as those described in U.S. Publication No. 2013/0268071, filed Nov. 30, 2012, and U.S. Pat. No. 8,604,098, filed Jul. 6, 2011, which are incorporated by reference herein in their entireties, by laser ablation, or by other methods to create opacity, as described in U.S. Publication 2013/0289543, filed Mar. 12, 2013, which is also by incorporated by reference herein in its entirety. Once the mask is in place, the process of providing and curing layers of photoreactive lens material can be continued such that the mask is embedded within the completed lens. The lens can be formed such that the mask can be imaged within the lens in a manner that provides the mask with the same physical properties as the lens, thus allowing the mask to flex with the lens without damage.
- As explained above, the manufacturing method can include an extraction process to remove impurities. For example, the method can include a chemical extraction process. During the chemical extraction process, the IOL can undergo a volumetric increase of at least about 5%, sometimes at least about 10%.
- In some implementations, it can be desirable to subject the IOL to the chemical extraction process without substantially changing optical performance. For example, the optical power of the IOL before extraction can be within about 0.5 diopters, preferably within about 0.3 diopters, or within about 0.2 diopters, or within about 0.1 diopters, of the optical power of the IOL after extraction.
- Conditional language, such as “can,” “could,” “might,” or “may,” unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements, and/or steps. Thus, such conditional language is not generally intended to imply that features, elements, and/or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without user input or prompting, whether these features, elements, and/or steps are included or are to be performed in any particular embodiment.
- The terms “approximately,” “about,” and “substantially” as used herein represent an amount close to the stated amount that still performs a desired function or achieves a desired result. For example, the terms “approximately”, “about”, and “substantially” may refer to an amount that is within less than 10% of, within less than 5% of, within less than 1% of, within less than 0.1% of, and within less than 0.01% of the stated amount.
- Although certain embodiments and examples have been described herein, it will be understood by those skilled in the art that many aspects of the methods and IOLs shown and described in the present disclosure may be differently combined and/or modified to form still further embodiments or acceptable examples. All such modifications and variations are intended to be included herein within the scope of this disclosure. A wide variety of designs and approaches are possible. No feature, structure, or step disclosed herein is essential or indispensable.
- Some embodiments have been described in connection with the accompanying drawings. However, it should be understood that the figures are not drawn to scale. Distances, angles, etc. are merely illustrative and do not necessarily bear an exact relationship to actual dimensions and layout of the devices illustrated. Components can be added, removed, and/or rearranged. Further, the disclosure herein of any particular feature, aspect, method, property, characteristic, quality, attribute, element, or the like in connection with various embodiments can be used in all other embodiments set forth herein. Additionally, it will be recognized that any methods described herein may be practiced using any device suitable for performing the recited steps.
- For purposes of this disclosure, certain aspects, advantages, and novel features are described herein. It is to be understood that not necessarily all such advantages may be achieved in accordance with any particular embodiment. Thus, for example, those skilled in the art will recognize that the disclosure may be embodied or carried out in a manner that achieves one advantage or a group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein.
- Moreover, while illustrative embodiments have been described herein, the scope of any and all embodiments having equivalent elements, modifications, omissions, combinations (e.g., of aspects across various embodiments), adaptations and/or alterations as would be appreciated by those in the art based on the present disclosure. The limitations in the claims are to be interpreted broadly based on the language employed in the claims and not limited to the examples described in the present specification or during the prosecution of the application, which examples are to be construed as non-exclusive. Further, the actions of the disclosed processes and methods may be modified in any manner, including by reordering actions and/or inserting additional actions and/or deleting actions. It is intended, therefore, that the specification and examples be considered as illustrative only, with a true scope and spirit being indicated by the claims and their full scope of equivalents.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/655,430 US20230031760A1 (en) | 2009-08-13 | 2022-03-18 | Intraocular lens with elastic mask |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23380409P | 2009-08-13 | 2009-08-13 | |
US23379409P | 2009-08-13 | 2009-08-13 | |
US12/856,492 US9492272B2 (en) | 2009-08-13 | 2010-08-13 | Masked intraocular implants and lenses |
US201361863833P | 2013-08-08 | 2013-08-08 | |
US14/454,585 US10004593B2 (en) | 2009-08-13 | 2014-08-07 | Intraocular lens with elastic mask |
US16/017,834 US10548717B2 (en) | 2009-08-13 | 2018-06-25 | Intraocular lens with elastic mask |
US16/722,490 US11311371B2 (en) | 2009-08-13 | 2019-12-20 | Intraocular lens with elastic mask |
US17/655,430 US20230031760A1 (en) | 2009-08-13 | 2022-03-18 | Intraocular lens with elastic mask |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/722,490 Continuation US11311371B2 (en) | 2009-08-13 | 2019-12-20 | Intraocular lens with elastic mask |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230031760A1 true US20230031760A1 (en) | 2023-02-02 |
Family
ID=52626314
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/454,585 Active US10004593B2 (en) | 2009-08-13 | 2014-08-07 | Intraocular lens with elastic mask |
US16/017,834 Active US10548717B2 (en) | 2009-08-13 | 2018-06-25 | Intraocular lens with elastic mask |
US16/722,490 Active US11311371B2 (en) | 2009-08-13 | 2019-12-20 | Intraocular lens with elastic mask |
US17/655,430 Pending US20230031760A1 (en) | 2009-08-13 | 2022-03-18 | Intraocular lens with elastic mask |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/454,585 Active US10004593B2 (en) | 2009-08-13 | 2014-08-07 | Intraocular lens with elastic mask |
US16/017,834 Active US10548717B2 (en) | 2009-08-13 | 2018-06-25 | Intraocular lens with elastic mask |
US16/722,490 Active US11311371B2 (en) | 2009-08-13 | 2019-12-20 | Intraocular lens with elastic mask |
Country Status (1)
Country | Link |
---|---|
US (4) | US10004593B2 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7628810B2 (en) | 2003-05-28 | 2009-12-08 | Acufocus, Inc. | Mask configured to maintain nutrient transport without producing visible diffraction patterns |
US10004593B2 (en) | 2009-08-13 | 2018-06-26 | Acufocus, Inc. | Intraocular lens with elastic mask |
WO2011020078A1 (en) | 2009-08-13 | 2011-02-17 | Acufocus, Inc. | Masked intraocular implants and lenses |
EP2464310B1 (en) | 2009-08-13 | 2019-02-27 | CorneaGen Inc. | Corneal inlay with nutrient transport structures |
WO2013082545A1 (en) | 2011-12-02 | 2013-06-06 | Acufocus, Inc. | Ocular mask having selective spectral transmission |
US9427922B2 (en) | 2013-03-14 | 2016-08-30 | Acufocus, Inc. | Process for manufacturing an intraocular lens with an embedded mask |
WO2016081493A1 (en) | 2014-11-19 | 2016-05-26 | Acufocus, Inc. | Fracturable mask for treating presbyopia |
US11696823B2 (en) | 2015-04-14 | 2023-07-11 | Z Optics, Inc. | High definition and extended depth of field intraocular lens |
US11547554B2 (en) | 2015-04-14 | 2023-01-10 | Z Optics, Inc. | High definition and extended depth of field intraocular lens |
ES2972581T3 (en) | 2015-10-05 | 2024-06-13 | Acufocus Inc | Intraocular lens molding methods |
EP3384342B1 (en) | 2015-11-24 | 2021-08-25 | AcuFocus, Inc. | Toric small aperture intraocular lens with extended depth of focus |
CO2017004085A1 (en) * | 2017-04-26 | 2018-10-31 | Fundacion Univ Del Norte | Intraocular implant |
DE102017112086A1 (en) * | 2017-06-01 | 2018-12-06 | Carl Zeiss Meditec Ag | Artificial eye lens with diffractive grating structure and method for producing an artificial eye lens |
DE102017112087A1 (en) | 2017-06-01 | 2018-12-06 | Carl Zeiss Meditec Ag | Artificial eye lens with laser-generated birefringent structure and method for producing an artificial eye lens |
DE102017112085A1 (en) * | 2017-06-01 | 2018-12-06 | Carl Zeiss Meditec Ag | Artificial eye lens with medicament depot formed therein and method for making an artificial eye lens |
US11364110B2 (en) | 2018-05-09 | 2022-06-21 | Acufocus, Inc. | Intraocular implant with removable optic |
GB201814535D0 (en) * | 2018-09-06 | 2018-10-24 | Uea Enterprises Ltd | Intraocular devices |
US11950997B2 (en) * | 2019-05-20 | 2024-04-09 | The Trustees Of The Stevens Institute Of Technology | Artificial cornea with double-side microtextured pHEMA hydrogel |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096077A (en) * | 1997-08-20 | 2000-08-01 | Thinoptx, Inc. | Deformable intraocular corrective lens |
US20070032866A1 (en) * | 2005-08-05 | 2007-02-08 | Valdemar Portney | Accommodating diffractive intraocular lens |
Family Cites Families (446)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2350421A (en) | 1941-01-22 | 1944-06-06 | William P Schoder | Method of producing inlaid jewels |
US2470927A (en) | 1947-01-10 | 1949-05-24 | South Chester Corp | Fastening means |
US3034403A (en) | 1959-04-03 | 1962-05-15 | Neefe Hamilton Res Company | Contact lens of apparent variable light absorption |
US3458870A (en) | 1964-05-25 | 1969-08-05 | William Stone Jr | Artificial corneal implants having a removable lens member |
US3270099A (en) | 1964-12-07 | 1966-08-30 | Richard N Camp | A method for making multi-focal length contact lenses |
GB1276003A (en) | 1969-03-10 | 1972-06-01 | Frank Auld | Corneal contact device |
US3578850A (en) | 1970-02-11 | 1971-05-18 | Alan H Grant | Anti-flare contact lens |
US3794414A (en) | 1972-05-12 | 1974-02-26 | Jessen Inc Wesley | Multiple focal contact lens |
US3776230A (en) | 1973-04-18 | 1973-12-04 | C Neefe | Method of rapidly reshaping the cornea to eliminate refractive errors |
US3877502A (en) | 1973-08-29 | 1975-04-15 | Hunckler Products Inc | Nut locking means and method for muffler clamps |
US3996627A (en) | 1975-09-22 | 1976-12-14 | American Optical Corporation | Artificial intraocular lens |
US4010496A (en) | 1975-10-01 | 1977-03-08 | Neefe Charles W | Bifocal lens which positions within the anterior chamber |
US4104338A (en) | 1976-04-30 | 1978-08-01 | Guerrieri Salvatore A | Bubble cap tray |
US4116439A (en) | 1976-09-30 | 1978-09-26 | C.F.F. Inc. | Pool ball |
DE2727410C3 (en) | 1977-06-18 | 1980-03-06 | Friedrichsfeld Gmbh Steinzeug- Und Kunststoffwerke, 6800 Mannheim | Keratoprosthesis |
US4210391A (en) | 1977-09-14 | 1980-07-01 | Cohen Allen L | Multifocal zone plate |
US4340283A (en) | 1978-12-18 | 1982-07-20 | Cohen Allen L | Phase shift multifocal zone plate |
US4767647A (en) | 1979-12-17 | 1988-08-30 | The D. L. Auld Company | Decorative emblem |
US4435050A (en) | 1980-02-26 | 1984-03-06 | Stanley Poler | Contact lens assembly with haptic and method for making the same |
US4298996A (en) | 1980-07-23 | 1981-11-10 | Barnet Ronald W | Magnetic retention system for intraocular lens |
DE3169818D1 (en) | 1980-08-05 | 1985-05-15 | Choyce David P | Intraocular lens |
US4450593A (en) | 1981-11-09 | 1984-05-29 | Lynell Medical Technology Inc. | Intraocular and contact lens construction |
US4402579A (en) | 1981-07-29 | 1983-09-06 | Lynell Medical Technology Inc. | Contact-lens construction |
SU1380743A1 (en) | 1982-02-15 | 1988-03-15 | Московский научно-исследовательский институт микрохирургии глаза | Artificial eye lens |
US4402396A (en) | 1982-02-16 | 1983-09-06 | Cooper Laboratories, Inc. | Intraocular lens case |
US4423728A (en) | 1982-02-26 | 1984-01-03 | Lieberman David M | Cam-guided trephine |
US4470159A (en) | 1982-03-03 | 1984-09-11 | Peyman Gholam A | Keratoprosthesis |
US4639105A (en) | 1982-09-13 | 1987-01-27 | Neefe Charles W | Spin cast ocular cosmetic device with color separation |
JPS5954527A (en) | 1982-09-22 | 1984-03-29 | Hashimoto Forming Co Ltd | Production of molding for vehicle |
US4505855A (en) | 1982-09-30 | 1985-03-19 | Massachusetts General Hospital | Transparent non-fibrilized collagen material by ultracentrifugation |
US4701038A (en) | 1983-01-31 | 1987-10-20 | Bausch & Lomb Incorporated | Cosmetic contact lens |
US4563565A (en) | 1983-03-02 | 1986-01-07 | Minnesota Mining And Manufacturing Company | Method for forming a peripheral edge on contact lenses |
US4512039A (en) | 1983-05-24 | 1985-04-23 | Lieberman David M | Method of offsetting postoperative astigmatism with an intraocular lens |
DE3332313A1 (en) | 1983-09-07 | 1985-04-04 | Titmus Eurocon Kontaktlinsen GmbH, 8750 Aschaffenburg | MULTIFOCAL, ESPECIALLY BIFOCAL, INTRAOCULAR ARTIFICIAL EYE LENS |
US4665913A (en) | 1983-11-17 | 1987-05-19 | Lri L.P. | Method for ophthalmological surgery |
US4596578A (en) | 1984-01-30 | 1986-06-24 | Kelman Charles D | Intraocular lens with miniature optic |
US5041133A (en) | 1984-04-11 | 1991-08-20 | Pharmacia Ab | Intraocular implant |
US4605409A (en) | 1984-05-21 | 1986-08-12 | Kelman Charles D | Intraocular lens with miniature optic having expandable and contractible glare-reducing means |
US4976732A (en) | 1984-09-12 | 1990-12-11 | International Financial Associates Holdings, Inc. | Optical lens for the human eye |
US4624669A (en) | 1984-09-26 | 1986-11-25 | Surgidev Corporation | Corneal inlay with holes |
US4575373A (en) | 1984-11-02 | 1986-03-11 | Johnson Don R | Laser adjustable intraocular lens and method of altering lens power |
US4669466A (en) | 1985-01-16 | 1987-06-02 | Lri L.P. | Method and apparatus for analysis and correction of abnormal refractive errors of the eye |
US4646720A (en) | 1985-03-12 | 1987-03-03 | Peyman Gholam A | Optical assembly permanently attached to the cornea |
US4669834A (en) | 1985-04-30 | 1987-06-02 | Richter Judy C | Light reflective contact lens |
US6264648B1 (en) | 1985-07-29 | 2001-07-24 | Bausch & Lomb Incorporated | Corneal curvature modification via internal ablation |
US4676791A (en) | 1985-08-01 | 1987-06-30 | Surgidev Corporation | Intraocular lens and method for making same |
US4676790A (en) | 1985-09-25 | 1987-06-30 | Kern Seymour P | Method of manufacture and implantation of corneal inlays |
US4678422A (en) | 1985-11-12 | 1987-07-07 | York Kenneth K | Systems and methods for precise, accurate formation of products by photoablation |
GB2185124B (en) | 1986-01-03 | 1989-10-25 | Choyce David P | Intra-corneal implant |
JPS62167343A (en) | 1986-01-20 | 1987-07-23 | Toagosei Chem Ind Co Ltd | Polyvinylidene fluoride composition |
DE3610833A1 (en) | 1986-04-01 | 1987-10-08 | Inprohold Ets | INTRAOCULAR IMPLANTATION LENS |
US4799931A (en) | 1986-05-14 | 1989-01-24 | Lindstrom Richard L | Intracorneal lens |
US5030230A (en) | 1986-05-16 | 1991-07-09 | Great Plains Eye Clinic, Ltd. | Corneal implant |
US5269812A (en) | 1986-05-16 | 1993-12-14 | White Thomas C | Methods and devices employed in replacement of the corneal endothelium |
US4807623A (en) | 1986-05-30 | 1989-02-28 | David M. Lieberman | Device for simultaneously forming two incisions along a path on an eye |
US4799784A (en) | 1986-06-23 | 1989-01-24 | Aran Safir | Visual vertex finder |
US4715858A (en) | 1986-07-25 | 1987-12-29 | Lindstrom Richard L | Epicorneal lens |
US4842782A (en) | 1986-10-14 | 1989-06-27 | Allergan, Inc. | Manufacture of ophthalmic lenses by excimer laser |
US4842599A (en) | 1986-10-28 | 1989-06-27 | Ann M. Bronstein | Prosthetic cornea and method of implantation therefor |
JPS63199908A (en) | 1987-02-10 | 1988-08-18 | 金沢 秀樹 | Fixing structure |
US6387379B1 (en) | 1987-04-10 | 2002-05-14 | University Of Florida | Biofunctional surface modified ocular implants, surgical instruments, medical devices, prostheses, contact lenses and the like |
AU594233B2 (en) | 1987-04-10 | 1990-03-01 | University Of Florida | Improved ocular implants and methods for their manufacture |
US4795462A (en) | 1987-08-24 | 1989-01-03 | Grendahl Dennis T | Cylindrically segmented zone of focus artificial lens |
US4798608A (en) | 1987-08-24 | 1989-01-17 | Grendahl Dennis T | Laminated zone of focus artificial lens |
US4817789A (en) | 1987-09-23 | 1989-04-04 | Allergan, Inc. | Lens container assembly |
US5171318A (en) | 1987-11-09 | 1992-12-15 | Chiron Ophthalmics, Inc. | Treated corneal prosthetic device |
US4830855A (en) | 1987-11-13 | 1989-05-16 | Landec Labs, Inc. | Temperature-controlled active agent dispenser |
US4851003A (en) | 1988-01-05 | 1989-07-25 | Lindstrom Richard L | Corneal implant lens with fixation holes |
US5112328A (en) | 1988-01-25 | 1992-05-12 | Refractive Laser Research & Development Program, Ltd. | Method and apparatus for laser surgery |
JPH01195852A (en) | 1988-01-29 | 1989-08-07 | Canon Inc | Contact lens |
US4815690A (en) | 1988-02-09 | 1989-03-28 | Shepherd Thomas H | Apparatus for the production of monolithic intraocular implants |
US5192316A (en) | 1988-02-16 | 1993-03-09 | Allergan, Inc. | Ocular device |
US4969912A (en) | 1988-02-18 | 1990-11-13 | Kelman Charles D | Human collagen processing and autoimplant use |
US5067961A (en) | 1988-02-18 | 1991-11-26 | Autogenesis Technologies, Inc. | Non-biodegradable two phase corneal implant and method for preparing same |
JPH027954A (en) | 1988-03-04 | 1990-01-11 | Alcon Surgical Inc | Manufacture of lens with colored periphery |
US4907586A (en) | 1988-03-31 | 1990-03-13 | Intelligent Surgical Lasers | Method for reshaping the eye |
US4994080A (en) | 1988-07-15 | 1991-02-19 | Shepard Dennis D | Optical lens having at least one stenopaeic opening located in the central area thereof |
US5034166A (en) | 1988-07-21 | 1991-07-23 | Allergan, Inc. | Method of molding a colored contact lens |
US5120121A (en) | 1988-07-21 | 1992-06-09 | Allergan, Inc. | Colored lens |
US5092880A (en) | 1988-10-21 | 1992-03-03 | Genjiro Ohmi | Method of determining the astigmatic power and the power for an intraocular lens, for a toric intraocular lens |
US5185107A (en) | 1988-10-26 | 1993-02-09 | Iovision, Inc. | Fabrication of an intraocular lens |
US4903695C1 (en) | 1988-11-30 | 2001-09-11 | Lri L P | Method and apparatus for performing a keratomileusis or the like operation |
GB8900616D0 (en) | 1989-01-12 | 1989-03-08 | Galley Geoffrey H | Methods of manufacturing contact lenses |
US5098443A (en) | 1989-03-23 | 1992-03-24 | University Of Miami | Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents |
US5358520A (en) | 1989-04-28 | 1994-10-25 | Nestle S.A. | Supplementary intraocular lens system |
US5055602A (en) | 1989-05-02 | 1991-10-08 | Bausch & Lomb Incorporated | Polymerizable dye |
US5013319A (en) | 1989-06-05 | 1991-05-07 | Mount Sinai School Of Medicine Of The City University Of New York | Apparatus and method for cornea marking |
FR2649605B1 (en) | 1989-07-13 | 1995-07-21 | France Chirurgie Instr | CORNEAN IMPLANT |
US4955904A (en) | 1989-08-21 | 1990-09-11 | The Beth Israel Hospital Association | Masked intraocular lens and method for treating a patient with cataracts |
FR2660859B1 (en) | 1990-04-12 | 1992-07-10 | Hanna Khalil | KERATOTOME FOR THE MAKING OF ARCIFORM INCISIONS. |
US5547468A (en) | 1990-07-12 | 1996-08-20 | University Of Miami | Instruments for use in performing gel injection adjustable keratoplasty |
US5607437A (en) | 1990-07-12 | 1997-03-04 | University Of Miami | Instruments for use in performing gel injection adjustable keratoplasty |
US5090955A (en) | 1990-07-12 | 1992-02-25 | University Of Miami | Gel injection adjustable keratoplasty |
US5372580A (en) | 1990-07-12 | 1994-12-13 | University Of Miami | Gel injection adjustable keratoplasty |
US5120120A (en) | 1990-07-27 | 1992-06-09 | Cohen Allen L | Multifocal optical device with spurious order suppression and method for manufacture of same |
IL95381A0 (en) | 1990-08-06 | 1991-06-30 | Wolman Michael | Rimless molded eyeglasses |
WO1992005694A1 (en) | 1990-10-05 | 1992-04-16 | University Of Florida | Improved ocular implants and methods for their manufacture |
US5314961A (en) | 1990-10-11 | 1994-05-24 | Permeable Technologies, Inc. | Silicone-containing polymers, compositions and improved oxygen permeable hydrophilic contact lenses |
US5260727A (en) | 1990-10-22 | 1993-11-09 | Oksman Henry C | Wide depth of focus intraocular and contact lenses |
DE4134320C2 (en) | 1990-10-22 | 1993-10-28 | Gerhard M Krahmer | Artificial hair |
JPH04158859A (en) | 1990-10-23 | 1992-06-01 | Seiko Epson Corp | Artificial cornea |
US5137441A (en) | 1990-10-30 | 1992-08-11 | Minnesota Mining And Manufacturing Company | Mold assembly for making an ocular lens blank |
US5288436A (en) | 1990-11-06 | 1994-02-22 | Colloptics, Inc. | Methods of fabricating a collagen lenticule precursor for modifying the cornea |
US5094521A (en) | 1990-11-07 | 1992-03-10 | Vision Research Laboratories | Apparatus for evaluating eye alignment |
US5290892A (en) | 1990-11-07 | 1994-03-01 | Nestle S.A. | Flexible intraocular lenses made from high refractive index polymers |
US5108427A (en) | 1991-01-07 | 1992-04-28 | Majercik Stephen M | Active pupillary prosthesis |
US5269795A (en) | 1991-07-03 | 1993-12-14 | Arnott Eric J | Trephine device for removing anterior epithelial cells from corneal surfaces |
US5147395A (en) | 1991-07-16 | 1992-09-15 | Allergan Inc. | Small incision endocapsulator IOL |
US5213749A (en) | 1991-07-31 | 1993-05-25 | Westinghouse Air Brake Company | Method of forming a rubber seal having a metallic insert |
JPH06509731A (en) | 1991-08-16 | 1994-11-02 | ギャリン,マイルス エイ | Drug-coated refractive anterior chamber insert |
JP3092233B2 (en) | 1991-09-04 | 2000-09-25 | 三菱化学株式会社 | Liquid crystalline polyesteramide |
US5196026A (en) | 1991-09-16 | 1993-03-23 | Chiron Ophthalmics, Inc. | Method of implanting corneal inlay lenses smaller than the optic zone |
US5864128A (en) | 1991-10-15 | 1999-01-26 | Geo Labs, Inc. | Lens with variable focal length |
US5647865A (en) | 1991-11-01 | 1997-07-15 | Swinger; Casimir A. | Corneal surgery using laser, donor corneal tissue and synthetic material |
JPH0539527U (en) | 1991-11-05 | 1993-05-28 | 株式会社メニコン | Corneal host marker |
JPH07503382A (en) | 1991-11-06 | 1995-04-13 | ライ,シュイ,ティー. | Corneal surgery device and method |
US5786883A (en) | 1991-11-12 | 1998-07-28 | Pilkington Barnes Hind, Inc. | Annular mask contact lenses |
US5578080A (en) | 1991-11-12 | 1996-11-26 | Henry H. McDonald | Plastic optical lens with reduced thickness light blocking segments, and anchoring means |
KR940703639A (en) | 1992-01-02 | 1994-12-12 | 윌리암 제이. 링크 | Corneal ring inlay and methods of use |
US5266241A (en) | 1992-02-12 | 1993-11-30 | Iolab Corporation | Haptic attachment for soft intraocular lens |
US5188494A (en) | 1992-04-21 | 1993-02-23 | Itt Corporation | Torque indicator device and method for use with a threaded fastener |
US5312330A (en) | 1992-05-20 | 1994-05-17 | Summit Technology, Inc. | Medical treatment of the eye involving removal of the epithelium |
US5292514A (en) | 1992-06-24 | 1994-03-08 | Minnesota Mining And Manufacturing Company | Azlactone-functional substrates, corneal prostheses, and manufacture and use thereof |
US5354331A (en) | 1992-07-15 | 1994-10-11 | Schachar Ronald A | Treatment of presbyopia and other eye disorders |
AU650156B2 (en) | 1992-08-05 | 1994-06-09 | Lions Eye Institute Limited | Keratoprosthesis and method of producing the same |
US5288293A (en) | 1992-09-24 | 1994-02-22 | Donnell Jr Francis E O | In vivo modification of refractive power of an intraocular lens implant |
US6090141A (en) | 1993-03-05 | 2000-07-18 | Lindstrom; Richard L. | Small intracorneal lens |
US5507740A (en) | 1993-05-03 | 1996-04-16 | O'donnell, Jr.; Francis E. | Corneal topography enhancement device |
US5474548A (en) | 1993-07-14 | 1995-12-12 | Knopp; Carl F. | Method of establishing a unique machine independent reference frame for the eye |
US5870167A (en) | 1993-07-14 | 1999-02-09 | Knopp; Carl F. | Apparatus and method for imaging anterior structures of the eye |
ATE172665T1 (en) | 1993-07-28 | 1998-11-15 | Iolab Corp | INTRAOCULAR LENS WITH BREAKPROOF HOLDER |
BR9407215A (en) | 1993-08-02 | 1996-09-17 | Keravision Inc | Segmented preformed intrastromal corneal implant |
BR9407170A (en) | 1993-08-02 | 1996-09-17 | Keravision Inc | Segmented foldable intrastromal corneal insertion |
WO1995005621A1 (en) | 1993-08-18 | 1995-02-23 | Abraham Gyoergy | Method and optical means for improving or modifying colour vision and method for making said optical means |
JP2812860B2 (en) | 1993-08-31 | 1998-10-22 | 株式会社メニコン | Intraocular lens |
US5603774A (en) * | 1993-09-27 | 1997-02-18 | Alcon Laboratories, Inc. | Method for reducing tackiness of soft acrylic polymers |
TW257671B (en) | 1993-11-19 | 1995-09-21 | Ciba Geigy | |
JP3439809B2 (en) | 1993-12-24 | 2003-08-25 | 京セラ株式会社 | Artificial cornea |
EP0738128B1 (en) | 1994-01-07 | 2004-09-01 | Addition Technology, Inc | System for inserting material into corneal stroma |
JP3406677B2 (en) | 1994-03-31 | 2003-05-12 | 京セラ株式会社 | Artificial cornea |
US20030060880A1 (en) | 1994-04-08 | 2003-03-27 | Vladimir Feingold | Toric intraocular lens |
US5837156A (en) | 1994-04-21 | 1998-11-17 | Cumming; J. Stuart | Methods of fabricating intraocular lenses and lens molds |
US6197019B1 (en) | 1994-04-25 | 2001-03-06 | Gholam A. Peyman | Universal implant blank for modifying corneal curvature and methods of modifying corneal curvature therewith |
US5507806A (en) | 1994-05-13 | 1996-04-16 | Pharmacia Iovision, Inc. | Multi-faceted intraocular lens |
US6302877B1 (en) | 1994-06-29 | 2001-10-16 | Luis Antonio Ruiz | Apparatus and method for performing presbyopia corrective surgery |
US5910537A (en) | 1994-07-22 | 1999-06-08 | Staar Surgical Company Inc. | Biocompatible, optically transparent, ultraviolet light absorbing, polymeric material based upon collagen and method of making |
JP3640690B2 (en) | 1994-10-03 | 2005-04-20 | 株式会社ニデック | Intraocular lens |
ATE262857T1 (en) | 1994-10-06 | 2004-04-15 | Vladimir Feingold | INTRAOCULAR CONTACT LENS |
JPH08164155A (en) | 1994-12-14 | 1996-06-25 | Nikon Corp | Illuminator for ophthalmology |
JP3625097B2 (en) | 1995-02-07 | 2005-03-02 | セイコーエプソン株式会社 | Colored contact lens and manufacturing method thereof |
US5653752A (en) | 1995-02-28 | 1997-08-05 | Keravision, Inc. | Adjustable devices for corneal curvature adjustment |
US5628795A (en) | 1995-03-15 | 1997-05-13 | Langerman David W | Spare parts for use in ophthalmic surgical procedures |
US6110166A (en) | 1995-03-20 | 2000-08-29 | Escalon Medical Corporation | Method for corneal laser surgery |
US5697923A (en) | 1995-03-29 | 1997-12-16 | Poler; Stanley | Corneal drape for use in performing a photorefractory keratectomy procedure |
US5652638A (en) | 1995-05-04 | 1997-07-29 | Johnson & Johnson Vision Products, Inc. | Concentric annular ring lens designs for astigmatism |
US5693094A (en) | 1995-05-09 | 1997-12-02 | Allergan | IOL for reducing secondary opacification |
US5752967A (en) | 1995-07-27 | 1998-05-19 | Kritzinger; Michiel S. | Corneal surface marker and marking method for improving laser centration |
USD375245S (en) | 1995-08-18 | 1996-11-05 | Irving Thomas W E | Pistol lock |
US6989008B2 (en) | 2001-03-23 | 2006-01-24 | Minu Llc | Adjustable ablatable inlay |
US6551307B2 (en) | 2001-03-23 | 2003-04-22 | Gholam A. Peyman | Vision correction using intrastromal pocket and flap |
US6280470B1 (en) | 1995-10-20 | 2001-08-28 | Gholam A. Peyman | Intrastromal corneal modification |
US5964748A (en) | 1995-10-20 | 1999-10-12 | Peyman; Gholam A. | Intrastromal corneal modification |
US5919185A (en) | 1997-04-25 | 1999-07-06 | Peyman; Gholam A. | Universal implant blank for modifying corneal curvature and methods of modifying corneal curvature therewith |
US20090069817A1 (en) | 1995-10-20 | 2009-03-12 | Acufocus, Inc. | Intrastromal corneal modification |
US5722971A (en) | 1995-10-20 | 1998-03-03 | Peyman; Gholam A. | Intrastromal corneal modification |
US20050143717A1 (en) | 2001-04-27 | 2005-06-30 | Peyman Gholam A. | Method of treatment of refractive errors using subepithelial or intrastromal corneal inlay with bonding coating |
US20010027314A1 (en) | 1995-10-20 | 2001-10-04 | Peyman Gholam A. | Intrastromal corneal modification via laser |
US6221067B1 (en) | 1995-10-20 | 2001-04-24 | Gholam A. Peyman | Corneal modification via implantation |
US6203538B1 (en) | 1995-11-03 | 2001-03-20 | Gholam A. Peyman | Intrastromal corneal modification |
FR2743154B1 (en) | 1995-12-29 | 1998-03-06 | Essilor Int | MULTIFOCAL ARTIFICIAL EYE LENS WITH ILLUMINATION TRANSPARENCY |
US5702440A (en) | 1996-01-26 | 1997-12-30 | Allergan | Multifocal ophthalmic lens for dim-lighting conditions |
US5624456A (en) | 1996-02-07 | 1997-04-29 | Hellenkamp; Johann F. | Automatic surgical device for cutting a cornea |
JPH11503657A (en) | 1996-02-09 | 1999-03-30 | ケラ ビジョン,インコーポレイテッド | Segmented intrastromal insert and method for altering corneal refractive properties |
US5628794A (en) | 1996-03-08 | 1997-05-13 | Lindstrom; Richard L. | Multifocal corneal implant lens having a hydrogelo coating |
US20020128710A1 (en) | 1996-03-18 | 2002-09-12 | Eggleston Harry C. | Modular intraocular implant |
US6171336B1 (en) | 1996-03-26 | 2001-01-09 | Mark R. Sawusch | Method, implant, and apparatus for refractive keratoplasty |
US5693268A (en) | 1996-04-01 | 1997-12-02 | Johnson & Johnson Vision Products, Inc. | Wedge demolding of cast lens mold assemblies |
US5925294A (en) | 1996-04-24 | 1999-07-20 | Hoya Corporation | Process for the production of an intraocular lens |
US5905561A (en) | 1996-06-14 | 1999-05-18 | Pbh, Inc. | Annular mask lens having diffraction reducing edges |
US5662706A (en) | 1996-06-14 | 1997-09-02 | Pbh, Inc. | Variable transmissivity annular mask lens for the treatment of optical aberrations |
US5746558A (en) | 1996-07-24 | 1998-05-05 | Lockheed Martin Corporation | Locking apparatus for fastening system |
US5728156A (en) | 1996-08-06 | 1998-03-17 | Prism Opthalmics, L.L.C. | Prismatic intraocular lenses and related methods of in situ alteration of their optical characteristics |
US5769889A (en) | 1996-09-05 | 1998-06-23 | Kelman; Charles D. | High myopia anterior chamber lens with anti-glare mask |
CA2271815C (en) | 1996-11-15 | 2010-01-19 | Diffraction Ltd. | In-line holographic mask for micromachining |
US20010041884A1 (en) | 1996-11-25 | 2001-11-15 | Frey Rudolph W. | Method for determining and correcting vision |
US5965330A (en) | 1996-12-06 | 1999-10-12 | Pbh, Inc. | Methods for fabricating annular mask lens having diffraction-reducing edges |
CA2229093A1 (en) | 1997-02-13 | 1998-08-13 | Joseph J. Berto | Handlebar device |
US6228114B1 (en) | 1997-04-01 | 2001-05-08 | Joseph Y. Lee | Adjustable corneal ring |
US20010034516A1 (en) | 1997-04-25 | 2001-10-25 | Peyman Gholam A. | Universal implant blank for modifying corneal curvature and methods of modifying corneal curvature therewith |
US6063073A (en) | 1997-04-25 | 2000-05-16 | Peyman; Gholam A. | Universal implant blank for modifying corneal curvature and methods of modifying corneal curvature therewith |
US5980040A (en) | 1997-06-30 | 1999-11-09 | Wesley Jessen Corporation | Pinhole lens and contact lens |
JPH1184125A (en) | 1997-09-12 | 1999-03-26 | Tokyo Ohka Kogyo Co Ltd | Photopolymerizable composition for color filter and production of color filter |
US5964776A (en) | 1997-09-24 | 1999-10-12 | Peyman; Gholam A. | Internal keratome apparatus and method for using the same to form a pocket/flap between layers of a live cornea |
MC2461A1 (en) | 1997-09-26 | 1998-12-18 | Exsymol Sa | Ophthalmic and implantable devices covered with a coating and methods for producing the latter |
RU2138837C1 (en) | 1997-10-31 | 1999-09-27 | Институт автоматики и электрометрии СО РАН | Raster diffraction-aperture mask to correct defective eye sight |
US5876442A (en) | 1998-01-15 | 1999-03-02 | Visioncare Ltd. | Intraocular lens implant with telescope support |
EP1084454B1 (en) | 1998-04-21 | 2016-03-09 | University of Connecticut | Free-form nanofabrication using multi-photon excitation |
US6201036B1 (en) | 1998-07-21 | 2001-03-13 | Mezhoiraslevoi Nauchno-Tekhnichesky Komplex “Mikrokhirurgia Glaza” | Light-curable polymer material, method for making an elastic intraocular lens, and an elastic intraocular lens |
CN1110711C (en) | 1998-07-24 | 2003-06-04 | 长春科利尔光学制品有限公司 | Resin glasses able to correct colour vision by reduce concave reflection |
MXPA01003343A (en) | 1998-10-02 | 2003-06-24 | Scient Optics Inc | Method for diagnosing and improving vision. |
US6178593B1 (en) | 1998-10-23 | 2001-01-30 | Robert J. Carlson | Vertical pin automobile door hinge wear compensator |
US20020010510A1 (en) | 1998-11-04 | 2002-01-24 | Thomas A. Silvestrini | Variable modulus corneal implant and fabrication methods |
US6228115B1 (en) | 1998-11-05 | 2001-05-08 | Bausch & Lomb Surgical, Inc. | Intraocular lenses with improved axial stability |
US6164777A (en) | 1998-12-16 | 2000-12-26 | Bausch & Lomb Incorporated | Color-imparting contact lenses with interference coating and method for making the same |
US6102946A (en) | 1998-12-23 | 2000-08-15 | Anamed, Inc. | Corneal implant and method of manufacture |
US6361560B1 (en) | 1998-12-23 | 2002-03-26 | Anamed, Inc. | Corneal implant and method of manufacture |
US6554424B1 (en) | 1999-03-01 | 2003-04-29 | Boston Innovative Optices, Inc. | System and method for increasing the depth of focus of the human eye |
JP2000249890A (en) | 1999-03-02 | 2000-09-14 | Olympus Optical Co Ltd | Diaphragm device |
US6997428B1 (en) | 1999-03-31 | 2006-02-14 | Novartis Ag | Contact lens mold |
US6138307A (en) | 1999-05-06 | 2000-10-31 | Surgical Concepts, Inc. | Corneal intra-stromel prostheses |
AU4318800A (en) | 1999-05-12 | 2000-12-05 | Menicon Co., Ltd | Ocular lens materials and process for producing the same |
US6152959A (en) | 1999-05-14 | 2000-11-28 | Portney; Valdemar | Iris fixated intraocular lens |
US6469844B1 (en) | 1999-06-02 | 2002-10-22 | Fuji Photo Film Co., Ltd. | Lens holding method and lens holder |
US6461384B1 (en) | 1999-06-17 | 2002-10-08 | Bausch & Lomb Incorporated | Intraocular lenses |
US6423093B1 (en) | 1999-09-14 | 2002-07-23 | The Lions Eye Institute Of Western Australia Incorporated | Method of insertion of keratoprostheses |
US6352764B1 (en) | 1999-08-09 | 2002-03-05 | 3M Innovative Properties Company | Multi-layer articles including UV-absorbing polymeric compositions |
US6217596B1 (en) | 1999-09-01 | 2001-04-17 | Samir G. Farah | Corneal surface and pupillary cardinal axes marker |
US7008396B1 (en) | 1999-09-03 | 2006-03-07 | Restorvision, Inc. | Ophthalmic device and method of manufacture and use |
US6280471B1 (en) | 1999-09-16 | 2001-08-28 | Gholam A. Peyman | Glare-free intraocular lens and method for using the same |
US6277146B1 (en) * | 1999-09-16 | 2001-08-21 | Gholam A. Peyman | Glare-free intraocular lens and method for using the same |
WO2001019364A1 (en) | 1999-09-16 | 2001-03-22 | Horn Gerald D | A method for optimizing pupil size using alpha antagonist |
US20020082288A1 (en) | 1999-09-16 | 2002-06-27 | Gerald Horn | Ophthalmic formulations comprising an imidazoline |
US6649722B2 (en) | 1999-12-10 | 2003-11-18 | Novartis Ag | Contact lens |
CA2295431A1 (en) | 2000-01-06 | 2001-07-06 | Scott Howard Phillips | Ophthalmic apparatus |
US6228113B1 (en) | 2000-01-10 | 2001-05-08 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Intracorneal astigmatic onlay |
US6391230B1 (en) | 2000-02-18 | 2002-05-21 | Bausch & Lomb Incorporated | Intraocular lens manufacturing process |
DE10010683A1 (en) | 2000-03-04 | 2001-09-06 | Morcher Gmbh | Intraoccular lens with a transparent central region and a radially adjoining iris diaphragm for correction/cover of an aniridia is produced as a single unit |
US6458141B1 (en) | 2000-03-10 | 2002-10-01 | Gholam A. Peyman | Method and apparatus for creating a flap in the cornea and incisions or shrinkage under the flap to correct vision disorders |
US6949093B1 (en) | 2000-03-21 | 2005-09-27 | Minu, L.L.C. | Adjustable universal implant blank for modifying corneal curvature and methods of modifying corneal curvature therewith |
US6436092B1 (en) | 2000-03-21 | 2002-08-20 | Gholam A. Peyman | Adjustable universal implant blank for modifying corneal curvature and methods of modifying corneal curvature therewith |
US6755858B1 (en) | 2000-04-07 | 2004-06-29 | Thomas C. White | Prosthetic corneal graft and method |
US7635388B1 (en) | 2000-05-04 | 2009-12-22 | Tyler Thomas D | Device and method for incremental correction of sight disorders and occular diseases |
JP3073059U (en) | 2000-05-09 | 2000-11-14 | 船井電機株式会社 | Lens holder |
US6554860B2 (en) | 2000-05-15 | 2003-04-29 | Bausch & Lomb Incorporated | Foldable iris fixated intraocular lenses |
KR100335722B1 (en) | 2000-05-17 | 2002-05-09 | 김쌍기 | Clored Lens For Beauty And Manufacturing Thereof |
US20010050750A1 (en) | 2000-06-08 | 2001-12-13 | Breger Joseph L. | Pinhole presbyopic contact lenses |
US6544286B1 (en) | 2000-07-18 | 2003-04-08 | Tissue Engineering Refraction, Inc. | Pre-fabricated corneal tissue lens method of corneal overlay to correct vision |
AR030341A1 (en) | 2000-08-14 | 2003-08-20 | Novartis Ag | MOLDED BIOMEDICAL ITEMS |
US6543610B1 (en) | 2000-09-12 | 2003-04-08 | Alok Nigam | System for packaging and handling an implant and method of use |
US6726322B2 (en) | 2000-09-28 | 2004-04-27 | Novartis Ag | Fenestrated lens for increased tear flow and method of making the same |
JP3709335B2 (en) | 2000-09-28 | 2005-10-26 | 株式会社ニデック | Ophthalmic equipment |
US6607527B1 (en) | 2000-10-17 | 2003-08-19 | Luis Antonio Ruiz | Method and apparatus for precision laser surgery |
US6335190B1 (en) | 2000-10-20 | 2002-01-01 | New England Biolabs, Inc. | Method for cloning and producing the BsmI restriction endonuclease in E. coli |
US6515006B2 (en) | 2000-11-08 | 2003-02-04 | Hmt Pharma, Inc. | Ophthalmic formulation which modulates dilation |
US6811256B1 (en) | 2000-12-08 | 2004-11-02 | Paul Douglas Becherer | Post-ophthalmologic procedure lenses and methods |
US20020167640A1 (en) | 2000-12-22 | 2002-11-14 | Francis Charles Auxilium | Contact lens with opaque iris pattern |
US20020120329A1 (en) | 2001-02-28 | 2002-08-29 | Allergan Sales, Inc. | Moveable intraocular lenses and combinations of intraocular lenses |
US20050222679A1 (en) | 2001-04-27 | 2005-10-06 | Peyman Gholam A | Bifocal implant and method for altering the refractive properties of the eye |
US20050182489A1 (en) | 2001-04-27 | 2005-08-18 | Peyman Gholam A. | Intraocular lens adapted for adjustment via laser after implantation |
US20050182488A1 (en) | 2001-04-27 | 2005-08-18 | Peyman Gholam A. | Implant and method for altering the refractive properties of the eye |
US6589280B1 (en) | 2001-05-11 | 2003-07-08 | Jeffrey E. Koziol | Method for producing a multifocal corneal surface using intracorneal microscopic lenses |
US7645299B2 (en) | 2001-05-11 | 2010-01-12 | Koziol Jeffrey E | Intracorneal lens system having connected lenses |
CA2455357C (en) | 2001-06-15 | 2009-09-01 | The University Of Houston System | Thin film optical detectors for retinal implantation and methods for making and using same |
US20020196409A1 (en) | 2001-06-22 | 2002-12-26 | Bausch & Lomb Incorporated | Lens with colored portion |
US6497700B1 (en) | 2001-06-28 | 2002-12-24 | Lahaye Leon C. | Multi-function surgical instrument for facilitating ophthalmic laser surgery |
US6655804B2 (en) | 2001-06-29 | 2003-12-02 | Daniel G. Streibig | Colored contact lens and method of making same |
US20030014042A1 (en) | 2001-07-13 | 2003-01-16 | Tibor Juhasz | Method of creating stromal pockets for corneal implants |
US6533416B1 (en) | 2001-07-20 | 2003-03-18 | Ocular Sciences, Inc. | Contact or intraocular lens and method for its preparation |
US6638304B2 (en) | 2001-07-20 | 2003-10-28 | Massachusetts Eye & Ear Infirmary | Vision prosthesis |
US20030045930A1 (en) | 2001-08-30 | 2003-03-06 | Allergan Sales, Inc. | Apparatus and methods for packaging intrcorneal implants and facilitating placement thereof |
US6702807B2 (en) | 2001-09-10 | 2004-03-09 | Minu, L.L.C. | Ablatable intracorneal inlay with predetermined refractive properties |
US6575573B2 (en) | 2001-10-17 | 2003-06-10 | Carl Zeiss Ophthalmic Systems, Inc. | Method and apparatus for measuring a corneal profile of an eye |
US6786926B2 (en) | 2001-11-09 | 2004-09-07 | Minu, L.L.C. | Method and apparatus for alignment of intracorneal inlay |
US7037338B2 (en) | 2001-12-14 | 2006-05-02 | Toshiyuki Nagamoto | Intraocular ring assembly and artificial lens kit |
AU2003210534A1 (en) | 2002-01-14 | 2003-07-30 | Advanced Medical Optics, Inc. | Accommodating intraocular lens with integral capsular bag ring |
MXPA04006954A (en) | 2002-01-17 | 2005-03-23 | Perez Edward | Methods for producing epithelial flaps on the cornea and for placement of ocular devices and lenses beneath an epithelial flap or membrane, epithelial delaminating devices, and structures of epithelium and ocular devices and lenses. |
US8048155B2 (en) | 2002-02-02 | 2011-11-01 | Powervision, Inc. | Intraocular implant devices |
WO2003079272A1 (en) | 2002-03-15 | 2003-09-25 | University Of Washington | Materials and methods for simulating focal shifts in viewers using large depth of focus displays |
US20030204258A1 (en) | 2002-04-24 | 2003-10-30 | Graham William M. | Posterior chamber phakic lens |
US20030216763A1 (en) | 2002-05-14 | 2003-11-20 | Patel Anilbhai S. | Method of determining the visual axis of an eye |
CN100442006C (en) | 2002-05-30 | 2008-12-10 | 维思克斯公司 | Tracking torsional eye orientation and position |
US6951556B2 (en) | 2002-07-01 | 2005-10-04 | Epstein Robert L | Method and apparatus for correcting off-center laser ablations in refractive surgery |
US6855163B2 (en) | 2002-07-19 | 2005-02-15 | Minu, Llc | Gradual correction of corneal refractive error using multiple inlays |
US7364674B1 (en) | 2002-07-23 | 2008-04-29 | Advanced Optical Technologies, Inc. | Corneal implants produced by irradiation of polymer films |
US20040019379A1 (en) | 2002-07-25 | 2004-01-29 | Advanced Medical Optics, Inc. | Intracorneal lens with flow enhancement area for increased nutrient transport |
KR101053792B1 (en) | 2002-08-09 | 2011-08-04 | 내셔날 리서치 카운실 오브 캐나다 | Biosynthetic Matrix and Uses thereof |
US20040106929A1 (en) | 2002-08-20 | 2004-06-03 | Samuel Masket | Method and apparatus for performing an accurately sized and placed anterior capsulorhexis |
WO2004024035A1 (en) | 2002-09-13 | 2004-03-25 | Ocular Sciences, Inc. | Devices and methods for improving vision |
US20040056371A1 (en) | 2002-09-25 | 2004-03-25 | Medennium, Inc. | Method of manufacturing ophthalmic lenses made from hydrophobic acrylic polymers |
US20040068317A1 (en) | 2002-10-07 | 2004-04-08 | Knight Patricia M. | Anterior chamber intraocular lens with size and position indicators |
US7387759B2 (en) | 2002-12-17 | 2008-06-17 | Novartis Ag | System and method for curing polymeric moldings having a masking collar |
US7628810B2 (en) | 2003-05-28 | 2009-12-08 | Acufocus, Inc. | Mask configured to maintain nutrient transport without producing visible diffraction patterns |
US20050288784A1 (en) | 2004-06-23 | 2005-12-29 | Peyman Gholam A | Bifocal intraocular telescope for low vision correction |
US6951391B2 (en) | 2003-06-16 | 2005-10-04 | Apollo Optical Systems Llc | Bifocal multiorder diffractive lenses for vision correction |
US20050046794A1 (en) | 2003-06-17 | 2005-03-03 | Silvestrini Thomas A. | Method and apparatus for aligning a mask with the visual axis of an eye |
ATE527570T1 (en) | 2003-06-30 | 2011-10-15 | Werner Fiala | INTRAOCULAR LENS OR CONTACT LENSES WITH LARGE DEPTH OF FOCUS |
JP4038454B2 (en) | 2003-07-31 | 2008-01-23 | 株式会社ニデック | Intraocular lens |
US20050033422A1 (en) | 2003-08-08 | 2005-02-10 | Advanced Medical Optics, Inc. | Glare reducing rough surfaces |
US7422604B2 (en) | 2003-08-28 | 2008-09-09 | Bausch & Lomb Incorporated | Preloaded IOL injector |
US20050056954A1 (en) | 2003-09-12 | 2005-03-17 | Devlin Brian Gerrard | Method for making contact lenses |
US20050137703A1 (en) | 2003-12-05 | 2005-06-23 | Vanderbilt University | Accommodative intraocular lens |
US7025455B2 (en) | 2003-12-19 | 2006-04-11 | J&J Vision Care, Inc. | Multifocal contact lenses having a pinhole |
US7281699B2 (en) | 2003-12-29 | 2007-10-16 | Bausch & Lomb Incorporated | Universal accommodating IOL holder for lens processing and packaging |
CA2552122A1 (en) * | 2003-12-29 | 2005-07-21 | Advanced Medical Optics, Inc. | Intraocular lenses having a visible light-selective-transmissive-region |
DE602004023758D1 (en) * | 2003-12-30 | 2009-12-03 | Advanced Medical Optics Inc | INTRAOCULAR LENS MATERIALS WITH FITNESS FOR THE E |
US20050187621A1 (en) | 2004-02-24 | 2005-08-25 | Brady Daniel G. | Foldable unitary intraocular lens |
TW201440760A (en) | 2004-07-16 | 2014-11-01 | Texas A & M Univ Sys | Organic arsenic compounds, uses of the same in treating cancer and pharmaceutical compositions comprising the same |
WO2006014738A2 (en) | 2004-07-22 | 2006-02-09 | Cornell Research Foundation, Inc. | Accommodating intraocular lens and methods of use |
US20060064077A1 (en) | 2004-08-13 | 2006-03-23 | Peyman Gholam A | Method for correcting hyperopia and presbyopia using a laser and an inlay outside the visual axis of eye |
CN100368846C (en) | 2004-08-13 | 2008-02-13 | 亚洲光学股份有限公司 | Camera lens with regulating mechanism |
US7061693B2 (en) * | 2004-08-16 | 2006-06-13 | Xceed Imaging Ltd. | Optical method and system for extended depth of focus |
EP1788982A4 (en) * | 2004-08-24 | 2007-12-26 | Vision Membrane Technologies I | Foldable intraocular lens with adaptable haptics |
JP4555030B2 (en) | 2004-09-02 | 2010-09-29 | 富士フイルム株式会社 | Microlens array, optical member, and manufacturing method of microlens array |
US20060184243A1 (en) | 2004-10-22 | 2006-08-17 | Omer Yilmaz | System and method for aligning an optic with an axis of an eye |
US7922326B2 (en) | 2005-10-25 | 2011-04-12 | Abbott Medical Optics Inc. | Ophthalmic lens with multiple phase plates |
BRPI0517017A (en) | 2004-10-25 | 2008-09-30 | Advanced Medical Optics Inc | ophthalmic lens with multiple phase plates |
DE102004055683B4 (en) | 2004-10-26 | 2006-09-07 | Carl Zeiss Surgical Gmbh | Eye Surgery Microscopy System and Method Therefor |
US7455691B2 (en) | 2004-11-03 | 2008-11-25 | Biovision, Ag | Intraocular and intracorneal refractive lenses |
US7491350B2 (en) | 2004-12-01 | 2009-02-17 | Acufocus, Inc. | Method of making an ocular implant |
US20060113054A1 (en) | 2004-12-01 | 2006-06-01 | Silvestrini Thomas A | Method of making an ocular implant |
US7446157B2 (en) | 2004-12-07 | 2008-11-04 | Key Medical Technologies, Inc. | Nanohybrid polymers for ophthalmic applications |
SE0403091D0 (en) | 2004-12-20 | 2004-12-20 | Amo Groningen Bv | New composition for injectable ophthalmic lenses |
DE102004061943A1 (en) | 2004-12-22 | 2006-07-06 | *Acri.Tec Gesellschaft für ophthalmologische Produkte mbH | Artificial iris replacement implantable in one eye |
US7976577B2 (en) | 2005-04-14 | 2011-07-12 | Acufocus, Inc. | Corneal optic formed of degradation resistant polymer |
US20060235428A1 (en) | 2005-04-14 | 2006-10-19 | Silvestrini Thomas A | Ocular inlay with locator |
US7842367B2 (en) | 2005-05-05 | 2010-11-30 | Key Medical Technologies, Inc. | Ultra violet, violet, and blue light filtering polymers for ophthalmic applications |
DE102005032041A1 (en) | 2005-07-08 | 2007-01-18 | Carl Zeiss Meditec Ag | Device and method for changing an optical and / or mechanical property of a lens implanted in an eye |
DE102005045197B4 (en) * | 2005-09-21 | 2010-12-09 | Schott Ag | Process for producing a hybrid optical lens |
KR20080070820A (en) | 2005-10-12 | 2008-07-31 | 셀룰라 바이오엔지니어링 인코포레이티드 | Resorbable cornea button |
JP4851342B2 (en) | 2005-10-20 | 2012-01-11 | 三菱レイヨン株式会社 | Light control film, laminated light control film, method for producing light control film, and method for producing laminated light control film |
CN1951843B (en) | 2005-10-21 | 2011-09-28 | 鸿富锦精密工业(深圳)有限公司 | Optic element forming device |
ITBO20050647A1 (en) | 2005-10-26 | 2007-04-27 | Marinella Bergamaschi | CONTACT LENSES PHOTOCROMATIC HOLES |
US20070129797A1 (en) | 2005-12-01 | 2007-06-07 | Revision Optics, Inc. | Intracorneal inlays |
GB0603734D0 (en) | 2006-02-24 | 2006-04-05 | Applied Multilayers Ltd | Method and apparatus for forming a coated optical lens |
US8113651B2 (en) | 2006-03-20 | 2012-02-14 | High Performance Optics, Inc. | High performance corneal inlay |
CN100484498C (en) | 2006-04-19 | 2009-05-06 | 华中科技大学 | A flexible retina chip and preparation method thereof |
US20070258143A1 (en) | 2006-05-08 | 2007-11-08 | Valdemar Portney | Aspheric multifocal diffractive ophthalmic lens |
EP2074472A2 (en) | 2006-05-31 | 2009-07-01 | Junzhong Liang | Methods and apparatus for improving vision |
US20080077238A1 (en) | 2006-09-21 | 2008-03-27 | Advanced Medical Optics, Inc. | Intraocular lenses for managing glare, adhesion, and cell migration |
US8568478B2 (en) | 2006-09-21 | 2013-10-29 | Abbott Medical Optics Inc. | Intraocular lenses for managing glare, adhesion, and cell migration |
JP4812592B2 (en) | 2006-10-27 | 2011-11-09 | パナソニック株式会社 | Manufacturing method of composite optical component |
US20080151190A1 (en) | 2006-12-21 | 2008-06-26 | Bentley Joseph R | Corneal measurment apparatus and a method of using the same |
US7641337B2 (en) | 2006-12-22 | 2010-01-05 | Bausch & Lomb Incorporated | Ophthalmic lens including photochromic material |
AR064985A1 (en) | 2007-01-22 | 2009-05-06 | E Vision Llc | FLEXIBLE ELECTROACTIVE LENS |
US20080306587A1 (en) | 2007-02-21 | 2008-12-11 | Jingjong Your | Lens Material and Methods of Curing with UV Light |
US20080255663A1 (en) | 2007-04-13 | 2008-10-16 | Akpek Esen K | Artificial Cornea and Method of Making Same |
US20080269884A1 (en) * | 2007-04-30 | 2008-10-30 | Alcon, Inc. | Graduated blue filtering intraocular lens |
CN101322663A (en) | 2007-06-14 | 2008-12-17 | 苏州六六视觉科技股份有限公司 | Intraocular lens with iris diaphragm |
US8414123B2 (en) | 2007-08-13 | 2013-04-09 | Novartis Ag | Toric lenses alignment using pre-operative images |
US9216080B2 (en) | 2007-08-27 | 2015-12-22 | Amo Groningen B.V. | Toric lens with decreased sensitivity to cylinder power and rotation and method of using the same |
US8747466B2 (en) | 2007-08-27 | 2014-06-10 | Amo Groningen, B.V. | Intraocular lens having extended depth of focus |
US8740978B2 (en) * | 2007-08-27 | 2014-06-03 | Amo Regional Holdings | Intraocular lens having extended depth of focus |
EP2224881B1 (en) | 2007-10-16 | 2014-04-23 | Donald Tan | Ophthalmic surgical device for endothelial keratoplasty for descemet's stripping automated endothelial keratoplasty (dsaek) surgery |
PL2211747T3 (en) | 2007-10-29 | 2019-12-31 | Junzhong Liang | Devices for refractive treatments of presbyopia |
US20090164008A1 (en) | 2007-12-21 | 2009-06-25 | Xin Hong | Lens surface with combined diffractive, toric, and aspheric components |
US8480734B2 (en) | 2007-12-27 | 2013-07-09 | Anew Optics, Inc. | Intraocular lens with accommodation |
EP2243052B1 (en) | 2008-02-15 | 2011-09-07 | AMO Regional Holdings | System, ophthalmic lens, and method for extending depth of focus |
JP5128308B2 (en) * | 2008-02-20 | 2013-01-23 | Hoya株式会社 | Intraocular lens manufacturing method |
US7780290B2 (en) | 2008-02-21 | 2010-08-24 | Abbott Medical Optics Inc. | Toric intraocular lens with spatially-variant astigmatism |
US8439498B2 (en) | 2008-02-21 | 2013-05-14 | Abbott Medical Optics Inc. | Toric intraocular lens with modified power characteristics |
WO2009117506A2 (en) | 2008-03-18 | 2009-09-24 | Pixeloptics, Inc. | Advanced electro-active optic device |
IL190577A0 (en) | 2008-04-02 | 2008-12-29 | Nulens Ltd | Cartridge for storing an iol and forceps for use therewith |
NL2001503C2 (en) | 2008-04-21 | 2009-10-22 | Oculentis B V | Intraocular lens. |
US8167940B2 (en) | 2008-05-06 | 2012-05-01 | Novartis Ag | Aspheric toric intraocular lens |
US9060847B2 (en) * | 2008-05-19 | 2015-06-23 | University Of Rochester | Optical hydrogel material with photosensitizer and method for modifying the refractive index |
US20090306773A1 (en) | 2008-06-04 | 2009-12-10 | Acufocus, Inc. | Opaque corneal insert for refractive correction |
KR20100004777A (en) | 2008-07-04 | 2010-01-13 | 김현호 | Intraocular lens and correction method of postoperative refractive error of intraocular lens |
MX2011000419A (en) | 2008-07-15 | 2011-02-24 | Alcon Inc | Accommodative iol with toric optic and extended depth of focus. |
SG2014008072A (en) | 2008-07-15 | 2014-05-29 | Alcon Inc | An extended depth of focus (edof) lens to increase pseudo-accommodation by utilizing pupil dynamics |
US8441731B2 (en) * | 2008-09-04 | 2013-05-14 | Innovega, Inc. | System and apparatus for pixel matrix see-through display panels |
US20100082017A1 (en) | 2008-09-26 | 2010-04-01 | Advanced Medical Optics, Inc. | Laser modification of intraocular lens |
JP2010104772A (en) * | 2008-09-30 | 2010-05-13 | Yoichi Mikawa | Intraocular lens |
US8292953B2 (en) | 2008-10-20 | 2012-10-23 | Amo Groningen B.V. | Multifocal intraocular lens |
US20120232649A1 (en) | 2008-11-20 | 2012-09-13 | Insight Innovations, Llc | Intraocular Lens Cell Migration Inhibition System |
MX2011005272A (en) | 2008-11-20 | 2011-06-21 | Insight Innovations Llc | Biocompatible biodegradable intraocular implant system. |
US7794633B2 (en) | 2008-11-26 | 2010-09-14 | Aptina Imaging Corporation | Method and apparatus for fabricating lens masters |
US8529060B2 (en) | 2009-02-19 | 2013-09-10 | Alcon Research, Ltd. | Intraocular lens alignment using corneal center |
US8646916B2 (en) | 2009-03-04 | 2014-02-11 | Perfect Ip, Llc | System for characterizing a cornea and obtaining an opthalmic lens |
US8633292B2 (en) | 2009-03-26 | 2014-01-21 | Signet Armorlite | Polyurethane-based photochromic optical materials |
WO2010118469A1 (en) | 2009-04-16 | 2010-10-21 | Peter Leo Macken | Surgical tool |
US20100312336A1 (en) | 2009-06-09 | 2010-12-09 | Xin Hong | Zonal diffractive multifocal intraocular lens with central monofocal diffractive region |
TW201103518A (en) | 2009-07-17 | 2011-02-01 | Alcon Inc | Accommodative IOL with toric optic and extended depth of focus |
EP2464310B1 (en) * | 2009-08-13 | 2019-02-27 | CorneaGen Inc. | Corneal inlay with nutrient transport structures |
WO2011020078A1 (en) | 2009-08-13 | 2011-02-17 | Acufocus, Inc. | Masked intraocular implants and lenses |
US10004593B2 (en) | 2009-08-13 | 2018-06-26 | Acufocus, Inc. | Intraocular lens with elastic mask |
JPWO2011030509A1 (en) | 2009-09-11 | 2013-02-04 | 株式会社トプコン | Ophthalmic surgery microscope |
WO2011047076A1 (en) | 2009-10-13 | 2011-04-21 | Acufocus, Inc. | Method and apparatus for centration of an ocular implant |
BR112012009422A2 (en) | 2009-10-20 | 2016-06-14 | Univelsal View Co Ltda | soft contact lens |
US20120309761A1 (en) | 2009-10-27 | 2012-12-06 | Agency For Science, Technology And Research | Fast-response photochromic nanostructured contact lenses |
USD656526S1 (en) | 2009-11-10 | 2012-03-27 | Acufocus, Inc. | Ocular mask |
EP2319457A1 (en) | 2009-11-10 | 2011-05-11 | Lenspecial S.r.L. | Vision aiding system comprising at least one intraocular dioptric lens |
GB2475550B (en) | 2009-11-23 | 2012-09-12 | Rayner Intraocular Lenses Ltd | Intraocular lens |
US8287593B2 (en) | 2009-11-24 | 2012-10-16 | Valdemar Portney | Adjustable multifocal intraocular lens system |
US20120245683A1 (en) | 2009-12-04 | 2012-09-27 | Acufocus, Inc. | Corneal implant for refractive correction |
US8857803B2 (en) | 2009-12-14 | 2014-10-14 | Novartis Ag | Devices and methods for holding an intraocular lens during the processing and packaging of the intraocular lens |
US20110172675A1 (en) | 2010-01-12 | 2011-07-14 | Acufocus, Inc. | Ocular inlay delivery system and method of use |
US8531783B2 (en) | 2010-02-09 | 2013-09-10 | Xceed Imaging Ltd. | Imaging method and system for imaging with extended depth of focus |
TW201138744A (en) | 2010-03-31 | 2011-11-16 | Alcon Inc | Adjustable intraocular lens system |
US8308800B2 (en) | 2010-04-09 | 2012-11-13 | Chu Milton W | Intraocular lenses with high contrast haptics, materials, and methods |
JP5511516B2 (en) | 2010-05-31 | 2014-06-04 | 株式会社ニデック | Ophthalmic equipment |
ES2634491T3 (en) | 2010-07-07 | 2017-09-28 | California Institute Of Technology | Photoinitiated on demand polymerization |
JP2013544116A (en) | 2010-10-18 | 2013-12-12 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション | Vision correction system |
RU2459598C2 (en) | 2010-12-01 | 2012-08-27 | Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" | Device for increasing rotation stability of toric intraocular lens |
USD645337S1 (en) | 2011-01-15 | 2011-09-20 | Group-A Autosports, Inc. | Small washer |
RU110978U1 (en) | 2011-03-23 | 2011-12-10 | Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" | TORIC Intraocular Lens Marked for Orientation |
RU2457812C1 (en) | 2011-03-23 | 2012-08-10 | Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" | Artificial intraocular lens |
RU2456968C1 (en) | 2011-03-23 | 2012-07-27 | государственное бюджетное учреждение "Уфимский научно-исследовательский институт глазных болезней Академии наук Республики Башкортостан (ГБУ "Уф НИИ ГБ АН РБ") | Method of toric intraocular lens implantation in children |
BR112013031234B1 (en) | 2011-06-06 | 2021-01-26 | Transitions Optical, Inc. | photochromic article |
CN103958167B (en) | 2011-11-29 | 2017-03-08 | 诺华股份有限公司 | For moulding the processing method of the lens forming surface of at least one half module of the mould of eye-use lens |
WO2013082545A1 (en) | 2011-12-02 | 2013-06-06 | Acufocus, Inc. | Ocular mask having selective spectral transmission |
US8950859B2 (en) | 2011-12-25 | 2015-02-10 | Global-Ok Vision, Inc. | Multi-focal optical lenses |
WO2013112589A1 (en) | 2012-01-24 | 2013-08-01 | Regents Of The University Of Colorado | Modular intraocular lens designs and methods |
RU2493801C1 (en) | 2012-01-31 | 2013-09-27 | Владимир Николаевич Трубилин | Marker of capsulorexis and astigmatic axis of toric intraocular lens |
DE112013001018T5 (en) | 2012-02-16 | 2014-10-30 | Acufocus, Inc. | A mask having ocular device for implantation next to an intraocular lens |
US9757227B2 (en) | 2012-04-20 | 2017-09-12 | Hanita Lenses | Intraocular assembly |
US20130289543A1 (en) | 2012-04-23 | 2013-10-31 | David Haydn Mordaunt | System and method for in situ creation of a small aperture intraocular lens |
RU2517488C2 (en) | 2012-04-26 | 2014-05-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СамГМУ Минздрава России) | Method of presbyopia correction |
RU134784U1 (en) | 2012-07-04 | 2013-11-27 | Общество с ограниченной ответственностью предприятие "Репер-НН" | Intraocular lens |
RU2511081C1 (en) | 2012-08-03 | 2014-04-10 | Владимир Николаевич Трубилин | Toric marker of capsulorrhexis |
WO2014054946A1 (en) | 2012-10-01 | 2014-04-10 | Akkolens International B.V. | Artificial asymmetrical pupil for extended depth of field |
US20140121767A1 (en) | 2012-10-31 | 2014-05-01 | Novartis Ag | Method and system for providing a toric intraocular lens |
RU2500368C1 (en) | 2012-11-09 | 2013-12-10 | федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Method of implanting toric intraocular lenses |
US20140131905A1 (en) | 2012-11-09 | 2014-05-15 | Acufocus, Inc. | Process for manufacturing an intraocular lens |
US8998984B2 (en) | 2013-01-14 | 2015-04-07 | Andrew F. Phillips | Adjustable toric intraocular lens |
US9204962B2 (en) | 2013-03-13 | 2015-12-08 | Acufocus, Inc. | In situ adjustable optical mask |
US9427922B2 (en) | 2013-03-14 | 2016-08-30 | Acufocus, Inc. | Process for manufacturing an intraocular lens with an embedded mask |
RU134049U1 (en) | 2013-04-02 | 2013-11-10 | Общество с ограниченной ответственностью "Приморский центр микрохирургии глаза" | TORIC INTRAOCULAR LENS WITH LABELING OF CYLINDRICAL COMPONENT |
EP3505145B1 (en) | 2013-04-17 | 2020-08-19 | Optimedica Corporation | Laser fiducials for axis alignment in cataract surgery |
ES2407457B1 (en) | 2013-05-07 | 2014-04-09 | Francisco Javier FERNÁNDEZ CAMBRA | Pre-operative toric axis corneal marker |
DE102013105738A1 (en) | 2013-06-04 | 2014-12-04 | Faramarz Madjlessi | Laser treatment device for refractive surgery |
BR102013015451A2 (en) | 2013-06-19 | 2014-06-10 | Claudio Lovaglio Cancado Trindade | SMALL OPENING INTRA-OCULAR IMPLANT (PINHOLE) FOR EXPANDING THE DEPTH OF FOCUS |
US9968295B2 (en) | 2013-08-07 | 2018-05-15 | Novartis Ag | Surgical guidance and planning software for astigmatism treatment |
WO2015021323A1 (en) | 2013-08-08 | 2015-02-12 | Acufocus, Inc. | Intraocular lens with elastic mask |
KR101504475B1 (en) | 2013-08-23 | 2015-03-20 | 주식회사 지앤아이솔루션 | Optical lens, fabrication appratus and fabrication method thereof |
WO2015069927A1 (en) | 2013-11-06 | 2015-05-14 | Nexisvision, Inc. | Bimodular contact lenses |
US9341864B2 (en) | 2013-11-15 | 2016-05-17 | Nexisvision, Inc. | Contact lenses having a reinforcing scaffold |
CN104127262B (en) | 2013-11-27 | 2016-07-27 | 爱博诺德(北京)医疗科技有限公司 | Astigmatism correction type artificial intraocular lenses and design thereof and production method |
CN203647535U (en) | 2013-11-27 | 2014-06-18 | 爱博诺德(北京)医疗科技有限公司 | Astigmatism correction type intraocular lens |
DE102013020706A1 (en) | 2013-12-10 | 2015-06-11 | Carl Zeiss Meditec Ag | Method for optimized selection of the IOL to be implanted in an eye |
HUE043202T2 (en) | 2013-12-20 | 2019-08-28 | Novartis Ag | Molds for making contact lenses |
US9782942B2 (en) | 2013-12-30 | 2017-10-10 | Verily Life Sciences Llc | Methods and apparatus for positioning a structure on a polymer layer |
JP6854079B2 (en) | 2014-01-16 | 2021-04-07 | 興和株式会社 | How to design a toric intraocular lens |
EP3116444A2 (en) | 2014-03-10 | 2017-01-18 | Amo Groningen B.V. | Dual-optic intraocular lens that improves overall vision where there is a local loss of retinal function |
WO2016081493A1 (en) | 2014-11-19 | 2016-05-26 | Acufocus, Inc. | Fracturable mask for treating presbyopia |
US9358103B1 (en) | 2015-02-10 | 2016-06-07 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
US20170049560A1 (en) | 2015-08-21 | 2017-02-23 | Scott A. Cherne | Intraocular Lens Holder |
ES2972581T3 (en) | 2015-10-05 | 2024-06-13 | Acufocus Inc | Intraocular lens molding methods |
EP3384342B1 (en) | 2015-11-24 | 2021-08-25 | AcuFocus, Inc. | Toric small aperture intraocular lens with extended depth of focus |
EP3649498A4 (en) | 2017-07-05 | 2021-03-24 | AcuFocus, Inc. | Protective lens holder |
AU2018330604A1 (en) | 2017-09-11 | 2020-04-02 | Amo Groningen B.V. | Methods and apparatuses to increase intraocular lenses positional stability |
CN111629692A (en) | 2017-09-20 | 2020-09-04 | 明视有限责任公司 | One-piece intraocular lens and method of making same |
SG11202005139RA (en) | 2017-12-21 | 2020-07-29 | Alcon Inc | Method for manufacturing toric contact lenses |
WO2019169084A1 (en) | 2018-03-01 | 2019-09-06 | Ellis Forrest J | Intraocular lens with centration lips |
US11364110B2 (en) | 2018-05-09 | 2022-06-21 | Acufocus, Inc. | Intraocular implant with removable optic |
US10932902B2 (en) | 2018-08-03 | 2021-03-02 | Johnson & Johnson Vision Care, Inc. | Dynamically tunable apodized multiple-focus opthalmic devices and methods |
WO2020107126A1 (en) | 2018-11-30 | 2020-06-04 | Ma Joseph J K | Electrochromatic optical devices, systems, and methods |
-
2014
- 2014-08-07 US US14/454,585 patent/US10004593B2/en active Active
-
2018
- 2018-06-25 US US16/017,834 patent/US10548717B2/en active Active
-
2019
- 2019-12-20 US US16/722,490 patent/US11311371B2/en active Active
-
2022
- 2022-03-18 US US17/655,430 patent/US20230031760A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096077A (en) * | 1997-08-20 | 2000-08-01 | Thinoptx, Inc. | Deformable intraocular corrective lens |
US20070032866A1 (en) * | 2005-08-05 | 2007-02-08 | Valdemar Portney | Accommodating diffractive intraocular lens |
Also Published As
Publication number | Publication date |
---|---|
US11311371B2 (en) | 2022-04-26 |
US10548717B2 (en) | 2020-02-04 |
US20200337834A1 (en) | 2020-10-29 |
US20180296322A1 (en) | 2018-10-18 |
US10004593B2 (en) | 2018-06-26 |
US20150073549A1 (en) | 2015-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11311371B2 (en) | Intraocular lens with elastic mask | |
US10583619B2 (en) | Process for manufacturing an intraocular lens with an embedded mask | |
US20220280285A1 (en) | Masked intraocular implants and lenses | |
US9943403B2 (en) | Fracturable mask for treating presbyopia | |
WO2015021323A1 (en) | Intraocular lens with elastic mask | |
US20140131905A1 (en) | Process for manufacturing an intraocular lens | |
WO2017062316A1 (en) | Methods of molding intraocular lenses | |
US11364110B2 (en) | Intraocular implant with removable optic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ACUFOCUS, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WEBB, R. KYLE;SIEMS, DANIEL DAVID;REBOUL, ADAM C.;AND OTHERS;SIGNING DATES FROM 20140904 TO 20141017;REEL/FRAME:061713/0049 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |